<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">R6TjvHDRsd7zzKD6HSRfmfN</article-id>
      <article-id pub-id-type="other">00010</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2009000200010</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(09)09200210</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2009000200010</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Resposta circulat&#243;ria &#224; caminhada de 50 m na unidade coronariana, na s&#237;ndrome coronariana aguda</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dias</surname>
            <given-names>Cristiane Maria Carvalho Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maiato</surname>
            <given-names>Ana C&#233;lia Carneiro de Almeida</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baqueiro</surname>
            <given-names>K&#225;tia Maria Moreno</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fiqueredo</surname>
            <given-names>Alessandra Maia Furtado</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosa</surname>
            <given-names>Fernanda Warken</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pitanga</surname>
            <given-names>Janaina Oliveira</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Ludmila Ivo Cat&#227;o de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guimar&#227;es</surname>
            <given-names>Arm&#234;nio Costa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Salvador</named-content>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">Escola Bahiana de Medicina e Sa&#250;de P&#250;blica</institution>
        <institution content-type="orgdiv1">Hospital Alian&#231;a </institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>02</month>
        <year>2009</year>
      </pub-date>
      <volume>92</volume>
      <issue>2</issue>
      <fpage>135</fpage>
      <lpage>142</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>11</month>
          <year>2007</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>03</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>04</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: Aus&#234;ncia de t&#233;cnica padronizada e monitorada para iniciar a reabilita&#231;&#227;o de pacientes com s&#237;ndrome coronariana aguda (SCA), na unidade coronariana. OBJETIVO: Descrever a t&#233;cnica e a resposta circulat&#243;ria &#224; caminhada de 50 m (C50m). M&#201;TODOS: Estudo experimental, transversal, com 65 pacientes com SCA; destes 36 (54%) com infarto agudo do mioc&#225;rdio (IAM), Killip I; 29 (45,2%) com angina inst&#225;vel (AI); 61,5% do sexo masculino, idade 62,8 &#177; 12,7 anos. Caminhada com in&#237;cio 45 &#177; 23 horas p&#243;s-internamento. Mensuraram-se press&#227;o arterial sist&#243;lica (PAS mmHg) e diast&#243;lica (PAD mmHg), freq&#252;&#234;ncia card&#237;aca (FC bpm), duplo produto (PAS mmHg X FC bpm), satura&#231;&#227;o perif&#233;rica de oxig&#234;nio (SpO2%), tempo de caminhada e percep&#231;&#227;o do esfor&#231;o pela escala de Borg (EB). Obtiveram-se medi&#231;&#245;es nas posi&#231;&#245;es supina, sentada e ortostase (fase 1 - estresse gravitacional), no final da caminhada e p&#243;s-repouso de 5 minutos (fase 2 - estresse f&#237;sico). RESULTADOS: Observou-se aumento da FC ao estresse gravitacional sentado (&#916; = 4,18) e em ortostase (&#916; = 2,69), (p &lt; 0,001). Houve eleva&#231;&#227;o p&#243;s-caminhada da PAS (&#916; = 4,84), (p &lt; 0,001); FC (&#916; = 4,68), (p &lt; 0,001); DP (&#916; = 344,97), (p = 0,004); e decr&#233;scimo da SpO2 (&#916; = -1,42), (p &lt; 0,001), com retorno dos valores basais ap&#243;s 5 minutos. O tempo de caminhada foi de 2'36" &#177; 1'17". Observou-se boa toler&#226;ncia ao exerc&#237;cio pela EB. Resposta da PAS &gt; 142 mmHg ao sentar associou-se com aumento significativo (p = 0,031) de 11 mmHg ao exerc&#237;cio em 13 pacientes com sobrepeso/obesidade e 85% com hipertens&#227;o. Verificaram-se efeitos adversos em 19 (29,2%) pacientes, tonturas em 23,1%, com impedimento da caminhada em tr&#234;s deles. CONCLUS&#195;O: Nesta amostra, ap&#243;s 24 horas do evento coronariano, n&#227;o se verificaram efeitos colaterais graves &#224; C50m.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Infarto do mioc&#225;rdio</kwd>
        <kwd>angina inst&#225;vel</kwd>
        <kwd>reabilita&#231;&#227;o</kwd>
        <kwd>atividade motora</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>06</day>
        <month>04</month>
        <year>2009</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> REABILITA&#199;&#195;O CARDIOVASCULAR</p>
    <p>Resposta circulat&#243;ria &#224; caminhada de 50 m na unidade coronariana, na s&#237;ndrome coronariana aguda</p>
    <p>
      <bold>Cristiane Maria Carvalho Costa Dias; Ana C&#233;lia Carneiro de Almeida Maiato; K&#225;tia Maria Moreno Baqueiro; Alessandra Maia Furtado Fiqueredo; Fernanda Warken Rosa; Janaina Oliveira Pitanga; Ludmila Ivo Cat&#227;o de Souza; Arm&#234;nio Costa Guimar&#227;es</bold>
    </p>
    <p> Escola Bahiana de Medicina e Sa&#250;de P&#250;blica (EBMSP), Hospital Alian&#231;a (HA), Salvador, BA - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> Aus&#234;ncia de t&#233;cnica padronizada e monitorada para iniciar a reabilita&#231;&#227;o de pacientes com s&#237;ndrome coronariana aguda (SCA), na unidade coronariana. </p>
    <p><bold>OBJETIVO:</bold> Descrever a t&#233;cnica e a resposta circulat&#243;ria &#224; caminhada de 50 m (C50m). </p>
    <p><bold>M&#201;TODOS:</bold> Estudo experimental, transversal, com 65 pacientes com SCA; destes 36 (54%) com infarto agudo do mioc&#225;rdio (IAM), Killip I; 29 (45,2%) com angina inst&#225;vel (AI); 61,5% do sexo masculino, idade 62,8 &#177; 12,7 anos. Caminhada com in&#237;cio 45 &#177; 23 horas p&#243;s-internamento. Mensuraram-se press&#227;o arterial sist&#243;lica (PAS mmHg) e diast&#243;lica (PAD mmHg), freq&#252;&#234;ncia card&#237;aca (FC bpm), duplo produto (PAS mmHg X FC bpm), satura&#231;&#227;o perif&#233;rica de oxig&#234;nio (SpO<sub>2</sub>%), tempo de caminhada e percep&#231;&#227;o do esfor&#231;o pela escala de Borg (EB). Obtiveram-se medi&#231;&#245;es nas posi&#231;&#245;es supina, sentada e ortostase (fase 1 - estresse gravitacional), no final da caminhada e p&#243;s-repouso de 5 minutos (fase 2 - estresse f&#237;sico). </p>
    <p><bold>RESULTADOS:</bold> Observou-se aumento da FC ao estresse gravitacional sentado (&#916; = 4,18) e em ortostase (&#916; = 2,69), (p &lt; 0,001). Houve eleva&#231;&#227;o p&#243;s-caminhada da PAS (&#916; = 4,84), (p &lt; 0,001); FC (&#916; = 4,68), (p &lt; 0,001); DP (&#916; = 344,97), (p = 0,004); e decr&#233;scimo da SpO<sub>2</sub> (&#916; = -1,42), (p &lt; 0,001), com retorno dos valores basais ap&#243;s 5 minutos. O tempo de caminhada foi de 2'36" &#177; 1'17". Observou-se boa toler&#226;ncia ao exerc&#237;cio pela EB. Resposta da PAS &gt; 142 mmHg ao sentar associou-se com aumento significativo (p = 0,031) de 11 mmHg ao exerc&#237;cio em 13 pacientes com sobrepeso/obesidade e 85% com hipertens&#227;o. Verificaram-se efeitos adversos em 19 (29,2%) pacientes, tonturas em 23,1%, com impedimento da caminhada em tr&#234;s deles. </p>
    <p><bold>CONCLUS&#195;O:</bold> Nesta amostra, ap&#243;s 24 horas do evento coronariano, n&#227;o se verificaram efeitos colaterais graves &#224; C50m.</p>
    <p><bold>Palavras-chave:</bold> Infarto do mioc&#225;rdio, angina inst&#225;vel, reabilita&#231;&#227;o, atividade motora.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A reabilita&#231;&#227;o f&#237;sica precoce de pacientes com eventos card&#237;acos agudos come&#231;ou com o <italic>armchair treatment</italic> proposto por Mitchell e cols.<sup>1</sup>, em Boston, em 1953, para pacientes com IAM. Este procedimento tinha como objetivo reduzir as complica&#231;&#245;es pulmonares, emb&#243;licas, auton&#244;micas e neuromusculares advindas de repouso ao leito, que se prolongavam por tr&#234;s a seis semanas<sup>1</sup>. Convertino<sup>2</sup>, em 2003, descreve que n&#227;o &#233; incomum o repouso prolongado no leito p&#243;s-IAM e p&#243;s-angioplastia, principalmente na unidade coronariana (UCO). Alerta sobre a freq&#252;&#234;ncia de intoler&#226;ncia ortost&#225;tica e taquicardia reflexa, efeitos adversos comuns nesses pacientes ao assumirem a posi&#231;&#227;o em ortostase. O programa de mobiliza&#231;&#227;o deve ser balanceado entre o risco da mobiliza&#231;&#227;o precoce e os efeitos delet&#233;rios secund&#225;rios ao repouso no leito<sup>3</sup>.</p>
    <p>A pr&#225;tica da reabilita&#231;&#227;o cardiovascular fase hospitalar (RCV1) foi inserida na UCO, aplic&#225;vel &#224; SCA<sup>2,4-9</sup>, iniciando-se, se poss&#237;vel, de 12 a 24 horas p&#243;s-evento<sup>3,7</sup>. A maioria dos protocolos indica o estresse gravitacional (EG) e caminhada como componentes da RCV1<sup>7-12</sup>, n&#227;o havendo, por&#233;m, consenso quanto &#224; monitoriza&#231;&#227;o da resposta circulat&#243;ria, que traduz o grau de estresse imposto ao sistema cardiovascular<sup>13</sup>, &#224; dist&#226;ncia e ao tempo da caminhada. </p>
    <p>Outro aspecto preocupante &#233; n&#227;o advertir os profissionais da equipe interdisciplinar sobre a heterogeneidade dessa popula&#231;&#227;o, com v&#225;rios fatores de risco associados<sup>3</sup>, potencial para induzir complica&#231;&#245;es ao EG e na caminhada. Com base na pr&#225;tica emp&#237;rica da RCV1 numa UCO, procurou-se descrever a t&#233;cnica da C50m, nas suas fases de EG e f&#237;sico, de acordo com a resposta circulat&#243;ria, permitindo uma programa&#231;&#227;o mais racional e segura da RCV1.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Realizou-se um estudo experimental, transversal, na UCO de hospital privado na cidade do Salvador, entre abril de 2006 a janeiro de 2007. Foram inclu&#237;dos pacientes portadores de SCA com libera&#231;&#227;o m&#233;dica para deambular, que n&#227;o tivessem sido submetidos a tratamento cir&#250;rgico para revasculariza&#231;&#227;o do mioc&#225;rdio, e orientados no tempo e no espa&#231;o. Foram exclu&#237;dos pacientes com libera&#231;&#227;o m&#233;dica que se recusaram a assinar o TCLE e qualquer condi&#231;&#227;o que, no momento da C50m, pudesse colocar o paciente em risco, tais como queixa de dor precordial, dispn&#233;ia, arritmia parox&#237;stica, altera&#231;&#227;o aguda do segmento ST e da onda T, FC basal &gt;100 bpm, SpO<sub>2</sub> &lt; 92%; 100 &lt;PAS &gt; 160 mmHg e PAD &gt;100 mmHg<sup>6 </sup>. </p>
    <p>Durante a coleta, recrutaram-se 94 pacientes com diagn&#243;stico de SCA, sendo exclu&#237;dos 23 pacientes de acordo com os crit&#233;rios de exclus&#227;o. Houve uma desist&#234;ncia e cinco recusas. A amostra foi composta por 65 pacientes, cujas principais caracter&#237;sticas cl&#237;nicas e demogr&#225;ficas est&#227;o ilustradas na <xref ref-type="table" rid="tab01">tabela 1</xref>. Destes, 36 (54,8%) tinham IAM, 24 (36,9%), sem supradesnivelamento ST e 12 (18,5%) com supradesnivelamento ST, e 29 (45,2%) tinham AI; predominou o sexo masculino 40 (61,5%) e a idade foi de 62,8 &#177;12,7 anos (varia&#231;&#227;o de 38 a 94 anos); 30 (46,2%) pacientes tinham educa&#231;&#227;o superior, e cinco (7,7%) eram analfabetos ou tinham prim&#225;rio incompleto; 38 (58,5%) eram economicamente ativos.</p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt01.jpg"/></table-wrap>
    <p>Dos fatores de risco associados, os mais freq&#252;entes foram: sedentarismo (76,9%), sobrepeso/obesidade (69,2%), sexo masculino (61,5%) e hipertens&#227;o arterial (63,1%). O &#237;ndice de massa corp&#243;rea (IMC) mostrou m&#233;dia elevada (27 &#177; 4,0 kg/m<sup>2</sup>) na faixa de sobrepeso/obesidade. O estudo cineangiogr&#225;fico, realizado em 47 pacientes (72,3%), revelou obstru&#231;&#227;o <underline>&gt;</underline>70%, uniarterial em 11(16,9%), biarterial em 12(18,3%) e triarterial em 8 (12,3%), com nove (13,8%) sendo tratados com angioplastia. Vasodilatador foi usado em 52 (80%) e betabloqueador em 47 (72,3%).</p>
    <p>A pesquisa foi aprovada pelo Comit&#234; de &#201;tica em Pesquisa da Escola Bahiana de Medicina (CEP n&#186; 75/2005).</p>
    <p>
      <bold>Caminhada de 50 m</bold>
    </p>
    <p>A dist&#226;ncia de 50 m representou o percurso habitual dos pacientes na sua primeira caminhada p&#243;s-evento, j&#225; realizada na rotina da UCO, pelo fisioterapeuta. As vari&#225;veis escolhidas para monitoriza&#231;&#227;o representam os principais indicadores da atividade do cora&#231;&#227;o como bomba e da regula&#231;&#227;o da hemodin&#226;mica da circula&#231;&#227;o sang&#252;&#237;nea: FC, PAS, PAD, duplo produto (DP) como reflexo indireto do consumo de oxig&#234;nio mioc&#225;rdico e SpO<sub>2</sub>, como reflexo da extra&#231;&#227;o perif&#233;rica de oxig&#234;nio. A EB complementou a avalia&#231;&#227;o subjetiva da resposta ao estresse induzido pela caminhada. </p>
    <p>A resposta circulat&#243;ria &#224; C50m foi monitorada em duas fases: </p>
    <p>&#149; Fase 1 - dec&#250;bito dorsal a 0&#186;, sentado no leito com as pernas pendentes e em ortostase. </p>
    <p>&#149; Fase 2 - ap&#243;s 3 minutos em ortostase<sup>14</sup>, durante e no final da caminhada, e na fase de recupera&#231;&#227;o e ap&#243;s 5 minutos<sup>15,16</sup>. </p>
    <p>Todos os pacientes foram submetidos &#224; avalia&#231;&#227;o cl&#237;nica, com registro de dados antropom&#233;tricos e cl&#237;nicos. O peso e a altura foram mensurados em balan&#231;a antropom&#233;trica W-200 (Welmy - Brasil). O c&#225;lculo do &#237;ndice de massa corp&#243;rea foi feito pela f&#243;rmula de Quetelet: IMC = peso em kg/altura em m<sup>2</sup>. </p>
    <p>A aferi&#231;&#227;o da press&#227;o arterial (PA) foi feita de acordo com as IV Diretrizes Brasileiras de Hipertens&#227;o<sup>17</sup>, utilizando a t&#233;cnica auscultat&#243;ria, com esfignoman&#244;metro aner&#243;ide e tensi&#244;metro Missouri (Mikatos-Brasil). A FC foi determinada com um Polar (Electro OY- Filand) e a SpO<sub>2</sub> com ox&#237;metro de pulso port&#225;til 1001 (Moriya - Brasil). A dura&#231;&#227;o da caminhada foi medida por cron&#244;metro Ferrari (Oregon - EUA). A medi&#231;&#227;o das vari&#225;veis circulat&#243;rias obedeceu a esta seq&#252;&#234;ncia: a PA ap&#243;s 5 minutos em dec&#250;bito dorsal a 0&#186;, no primeiro minuto ap&#243;s sentar, no primeiro e terceiro minutos ap&#243;s assumir a ortostase, no primeiro minuto no final da caminhada e no quinto minuto de recupera&#231;&#227;o; a FC e a SpO<sub>2</sub> foram monitoradas continuadamente, com registro dos valores coincidindo com o in&#237;cio da medida da PA. </p>
    <p>No in&#237;cio da caminhada, o paciente foi interrogado quanto &#224; presen&#231;a de qualquer desconforto, se estava disposto a realiz&#225;-la e orientado para interromper a caminhada se apresentasse algum tipo de desconforto. A EB utilizada foi a modificada (0-10), por ser mais atualizada<sup>18</sup>. Aplicada no in&#237;cio e no final da caminhada, os pacientes foram orientados para n&#227;o ultrapassar o n&#237;vel quatro (ligeiramente cansativo), limite m&#225;ximo de seguran&#231;a para atividade f&#237;sica nesta fase<sup>6</sup>. A C50m foi acompanhada pelo fisioterapeuta que registrou FC<sub>m&#225;x</sub> e SpO<sub>2min</sub>; n&#227;o houve est&#237;mulo verbal quanto ao ritmo e &#224; velocidade da caminhada. O pr&#243;prio paciente ditou o seu ritmo; ao final da caminhada, foram registrados os par&#226;metros circulat&#243;rios e o n&#237;vel da EB.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>
      <bold>C&#225;lculo do tamanho amostral</bold>
    </p>
    <p>Esse c&#225;lculo baseou-se na vari&#225;vel de desfecho FC, considerado indicador da resposta funcional do paciente. A hip&#243;tese a ser testada foi de que a FC aumentaria com o estresse f&#237;sico da C50m, sendo a magnitude desse efeito (E) estimada em +4bpm, caracterizando a an&#225;lise como unidirecional. Por sua vez, a variabilidade do desfecho (aumento da FC) foi estimada com base no desvio padr&#227;o (S) da m&#233;dia da FC, o qual foi calculado como &#188; de uma varia&#231;&#227;o da FC de 70 a 100 bpm (considerando que muitos desses pacientes usavam BB): DP = 30&#247;4= &#177;7,5 bpm. Calculou-se ent&#227;o a magnitude da amplitude padronizada do efeito (E/S), que foi definida pelo quociente da amplitude total do intervalo (4) pelo DP (7,5): 4&#247;7,5 = 0,53. De posse desses valores e para um &#945; = 0,05 (n&#237;vel de signific&#226;ncia) e &#946; = 0,20 (poder do estudo), encontrou-se um N de 51 pacientes, o qual, acrescido de 20% para compensar perdas, alcan&#231;ou um m&#237;nimo de 62 pacientes<sup>19</sup>.</p>
    <p>As vari&#225;veis independentes foram: sexo, idade, atividade f&#237;sica, IMC, tipo da SCA, dislipidemia, hipertens&#227;o, diabete, tabagismo, uso de vasodilatador e betabloqueador. As var&#225;veis dependentes foram: PAS, PAD, FC, DP, SpO<sub>2</sub>, EB e a dura&#231;&#227;o da caminhada. O banco de dados e a an&#225;lise descritiva e anal&#237;tica foram feitos com o aux&#237;lio do <italic>software</italic> Statistical Package for Social Sciences (SPSS), vers&#227;o 12.0 para Windows. A an&#225;lise de normalidade da distribui&#231;&#227;o de vari&#225;veis cont&#237;nuas foi realizada pelo teste de Kolmogorov-Smirnov.</p>
    <p>Vari&#225;veis categ&#243;ricas foram expressas em valores percentuais (%), vari&#225;veis cont&#237;nuas, com distribui&#231;&#227;o normal, em m&#233;dia e desvio padr&#227;o (X&#177;DP) e com distribui&#231;&#227;o assim&#233;trica em mediana e intervalo interquart&#237;lico. </p>
    <p>O teste do qui-quadrado foi utilizado para compara&#231;&#227;o das vari&#225;veis categ&#243;ricas, e, quando inadequado, empregou-se o teste exato de Fischer. A an&#225;lise de compara&#231;&#227;o da EB (pr&#233; e p&#243;s) foi feita pelo teste de McNemar.</p>
    <p>A signific&#226;ncia estat&#237;stica da diferen&#231;a entre as m&#233;dias das vari&#225;veis nas fases do EG e da caminhada foi estabelecida pelo teste <italic>t</italic> de <italic>Student</italic> para amostras pareadas e a compara&#231;&#227;o das mesmas vari&#225;veis entre os preditores de risco pelo teste t de Student para amostras independentes. Em alguns casos, essas compara&#231;&#245;es foram feitas pelos testes U e T de Wilcoxon, respectivamente. O n&#237;vel de signific&#226;ncia foi de 5%.</p>
    <p>O estudo foi financiado pela Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado da Bahia.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>
      <bold>Caminhada de 50 m</bold>
    </p>
    <p>A C50m foi aplicada 45,0 &#177; 23,0 horas p&#243;s-internamento, variando de 24 a 48 horas em 27 (41,5%) pacientes, 10 (27,8%) dos quais tinham IAM; de 48 a 72 horas em 33 (50,8%) e entre 96 e 120 horas em quatro (6,2%); apenas um paciente realizou o teste no quinto dia de admiss&#227;o. A variabilidade do tempo de aplica&#231;&#227;o decorreu do tempo da &#250;ltima crise de angina e da realiza&#231;&#227;o de cateterismo e/ou angioplastia, com um per&#237;odo de espera de &#177; 24 horas.</p>
    <p>
      <bold>Comportamento de vari&#225;veis circulat&#243;rias e dura&#231;&#227;o da C50m</bold>
    </p>
    <p>Os valores basais da m&#233;dia das vari&#225;veis circulat&#243;rias em estudo, mensuradas em dec&#250;bito dorsal a 0<underline>&#176;</underline>, foram os seguintes: PAS 128,8 &#177;15,0 mmHg; PAD 73,8 &#177;12,5 mmHg; FC 70,9&#177;10,4 bpm; DP 10.007 &#177; 77,07 mmHgXbpm; e SpO<sub>2 </sub>95&#177;2,0 %, valores normais. A mudan&#231;a de posi&#231;&#227;o do dec&#250;bito dorsal de 0&#186; para a posi&#231;&#227;o sentada e posterior assun&#231;&#227;o da ortostase provocou aumento significativo da FC, &#916;+4,18 bpm (p&lt;0,001) e &#916; +2,69 bpm (p &lt; 0,001), respectivamente, contudo sem repercuss&#227;o cl&#237;nica (<xref ref-type="table" rid="tab02">tab. 2</xref>).</p>
    <table-wrap id="tab02">
      <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt02.jpg"/></table-wrap>
    <p>No final da caminhada, observou-se aumento nos valores da PAS, &#916; +4,84 mmHg (p &lt; 0,001), FC, &#916; +4,68 bpm (p &lt; 0,001), e DP, &#916; +344,97 mmHgxbpm (p = 0,004), e queda da SpO<sub>2</sub>&#916; -1,42% (p &lt; 0,001), todos significativos, mas sem repercuss&#227;o cl&#237;nica. Na fase de recupera&#231;&#227;o, ap&#243;s cinco minutos na posi&#231;&#227;o sentada, as vari&#225;veis estudadas apresentaram redu&#231;&#227;o significativa (PAS, &#916; -4,53 mmHg, p&lt;0,024, FC, &#916; -9,06 bpm, DP, &#916; - 869,42 mmHgxbpm, p&lt;0,001 e PAD, &#916; -3,14 mmHg, p=0,006), com exce&#231;&#227;o da SpO<sub>2 </sub>que mostrou aumento significativo, &#916;+2,16%, p&lt;0,001, todas elas retornando rapidamente aos valores basais (<xref ref-type="table" rid="tab02">tab. 2</xref>). A dura&#231;&#227;o da C50m apresentou valor m&#233;dio de 2,5 &#177; 1,3 min.</p>
    <p>A percep&#231;&#227;o das fases de EG e f&#237;sico pela EB revelou um desvio para a direita em rela&#231;&#227;o aos escores basais. Na fase pr&#233;-caminhada, 33 (53,2%) indiv&#237;duos referiram "aus&#234;ncia de dispn&#233;ia" (escore 0), 27 (43,5%) "muito muito leve" e de "muito leve a leve" (escore de 0,5 a 2) e 2 (3,2%) " moderada" (escore 3). No final da caminhada, a distribui&#231;&#227;o dessas percep&#231;&#245;es passou a 25 (40,3%), 29 (46,8%) e 7 (11,3%), respectivamente, acrescida de um (1,6%) paciente cuja dispn&#233;ia tornou-se mais intensa (escore 4). Essa paciente tinha AI, 64 anos, era fumante e obesa.</p>
    <p>
      <bold>Variabilidade das vari&#225;veis circulat&#243;rias entre os preditores de risco</bold>
    </p>
    <p>O EG da posi&#231;&#227;o sentada a partir do dec&#250;bito dorsal 0&#186; provocou varia&#231;&#227;o divergente do &#916; PAS, com signific&#226;ncia estat&#237;stica, mas sem repercuss&#227;o cl&#237;nica, em sedent&#225;rios e diab&#233;ticos. Nos sedent&#225;rios, houve aumento do &#916;PAS de +1,68 mmHg, enquanto nos fisicamente ativos verificou-se diminui&#231;&#227;o de -4,71 mmHg (p = 0,030) (<xref ref-type="table" rid="tab03">tab. 3</xref>). Nos diab&#233;ticos, houve diminui&#231;&#227;o do &#916;PAS de -3,5 mmHg, enquanto nos n&#227;o-diab&#233;ticos verificou-se aumento de +2 mmHg (p = 0,012) (<xref ref-type="table" rid="tab03">tab. 3</xref>). A varia&#231;&#227;o da FC foi positiva em todos, inclusive nos pacientes em uso de betabloqueador.</p>
    <table-wrap id="tab03">
      <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt03.jpg"/></table-wrap>
    <p>Em rela&#231;&#227;o ao EG da ortostase, n&#227;o houve varia&#231;&#227;o significativa da PAS, mas verificou-se varia&#231;&#227;o significativa do comportamento da FC entre pacientes com idade menor e <underline>&gt;</underline> 63 anos de idade (valor da mediana da idade da amostra), por&#233;m sem repercuss&#227;o cl&#237;nica. Os indiv&#237;duos com idade <underline>&gt;</underline> 63 anos apresentaram um &#916;FC de +0,73 bpm, em oposi&#231;&#227;o ao aumento de +4,72 bpm nos pacientes com idade &lt; 63 anos, p = 0,002 (<xref ref-type="table" rid="tab03">tab. 3</xref>). </p>
    <p>Ap&#243;s o estresse f&#237;sico, o &#916; PAS nos diab&#233;ticos foi de 2,17 mmHg, enquanto nos n&#227;o-diab&#233;ticos foi de 6,41 mmHg, com valor de p muito pr&#243;ximo do n&#237;vel de signific&#226;ncia (0,061). Nos diab&#233;ticos, o &#916;FC foi de +8,39 bpm, significativamente maior do que nos n&#227;o-diab&#233;ticos (&#916;FC +2,49 bpm, p = 0,017) (<xref ref-type="table" rid="tab03">tab. 3</xref>). Com o uso de betabloqueador, houve mudan&#231;a na FC e na PAS, por&#233;m sem signific&#226;ncia estat&#237;stica e cl&#237;nica. Quanto &#224; dura&#231;&#227;o, a C50m n&#227;o mostrou diferen&#231;a significativa entre os preditores de risco. Por&#233;m, naqueles com idade <underline>&gt;</underline> 63 anos, a dura&#231;&#227;o m&#233;dia da C50m foi a mais longa, 2 min 52s &#177; 1,37, em oposi&#231;&#227;o aos fisicamente ativos, com a menor m&#233;dia, 1 min 98s &#177;0,80.</p>
    <p>
      <bold>Comportamento de valores extremos em resposta &#224; C50m</bold>
    </p>
    <p>O grupo que apresentou valores da PAS <underline>&gt;</underline> 142 mmHg ao sentar revelou aumento significativo da &#916;PAS de +2,00 mmHg (p = 0,013) em rela&#231;&#227;o ao dec&#250;bito dorsal de 0&#186;, com valor m&#225;ximo da PAS de 154 mmHg; ap&#243;s a C50m, o &#916;PAS aumentou de +11 mmHg, p = 0,013, com valor m&#225;ximo da PAS de 160 mmHg. Na recupera&#231;&#227;o, o &#916; PAS foi de -3 mmHg, sem signific&#226;ncia e o valor m&#225;ximo da PAS caiu para 153 mmHg (<xref ref-type="table" rid="tab04">tab. 4</xref>). A FC revelou aumento significativo ao sentar, com &#916;FC de +4,00 bpm, p = 0,004, pico de 80 bpm; e ap&#243;s a caminhada, &#916;FC de +3,5 bpm, p &lt; 0,001, pico de 81 bpm, com redu&#231;&#227;o significativa na fase de recupera&#231;&#227;o (&#916;FC-6,50 bpm, p = 0,017), pico de 75 bpm (<xref ref-type="table" rid="tab04">tab. 4</xref>). Nos pacientes que apresentaram PAS <underline>&lt;</underline> 114 mmHg, ao sentar, esta manteve-se est&#225;vel, enquanto a FC apresentou aumento significativo (&#916;FC +4,5 bpm, p = 0,004) ao sentar, na ortostase (&#916;FC +3,0 bpm, p = 0,013); e ap&#243;s a caminhada (&#916;FC +5,0 bpm, p = 0,014), com aumento cumulativo de 12,5 bpm e pico na caminhada de 95 bpm. Na recupera&#231;&#227;o, houve desacelera&#231;&#227;o significativa de 10 bpm (p = 0,001), caindo o pico da FC para 88 bpm (<xref ref-type="table" rid="tab04">tab. 4</xref>). </p>
    <table-wrap id="tab04">
      <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt04.jpg"/></table-wrap>
    <p>Dentre os preditores de risco considerados, todos os 13 (100,0%) pacientes que apresentaram resposta extrema com PAS <underline>&gt;</underline> 142 mmHg tinham sobrepeso/ obesidade, comparados aos 8 (50,0%) dos 16 com resposta extrema da PAS <underline>&lt;</underline> 114 mmHg, p = 0,030; e 11 pacientes (85,0%) tinham hipertens&#227;o <italic>vs</italic> 7 (44,0%) respectivamente, p = 0,0524.</p>
    <p>
      <bold>Efeitos adversos &#224; caminhada de 50 m</bold>
    </p>
    <p>Efeitos adversos foram observados na fase de EG da ortostase em 19 (29,2%) pacientes, sendo tontura o mais freq&#252;ente, ocorrendo em 15 (23,1%), seguida de hipotens&#227;o postural em quatro pacientes (6,3%). Com exce&#231;&#227;o de tr&#234;s pacientes, nos quais houve necessidade de interrup&#231;&#227;o da caminhada, um paciente apresentou precordialgia, outro, pico hipertensivo (PA = 168 X 110 mmHg), e o terceiro, hipotens&#227;o com tontura (PA = 100 X 88 mmHg, com &#916; PAS =-18 mmHg). Todos tr&#234;s apresentaram sudorese profusa e estavam em uso de betabloqueador e vasodilatador. </p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>O presente estudo descreve o comportamento de vari&#225;veis circulat&#243;rias &#224; C50m na UTIC, em pacientes com SCA, atendendo &#224; diretriz da SBC, que preconiza reabilita&#231;&#227;o cardiovascular na fase hospitalar para pacientes com esse perfil cl&#237;nico<sup>6,8,9,11</sup>. Para o sucesso dessa reabilita&#231;&#227;o, por&#233;m, &#233; necess&#225;rio monitorar a resposta circulat&#243;ria, o que foi feito neste estudo.</p>
    <p>Os fatores de risco associados s&#227;o habituais entre pacientes com esse tipo de patologia, como revela o elevado percentual de pacientes sedent&#225;rios, com sobrepeso/obesidade, hipertensos, diab&#233;ticos, o que constitui risco adicional para a aplica&#231;&#227;o da C50m. Este fato indica a import&#226;ncia de padronizar e monitorar o impacto sobre o aparelho cardiovascular do EG e f&#237;sico da C50m, como meio de garantir o processo de reabilita&#231;&#227;o precoce. Considerando as altera&#231;&#245;es fisiopatol&#243;gicas decorrentes do repouso no leito, a literatura retrata a import&#226;ncia de incrementar o EG e a caminhada t&#227;o logo seja poss&#237;vel<sup>2</sup>. Essa pr&#225;tica, contudo, s&#243; &#233; indicada para pacientes com SCA est&#225;vel<sup>6, 8,9,11</sup>.</p>
    <p>A m&#233;dia do tempo de aplica&#231;&#227;o da C50m reflete o cuidado de que a reabilita&#231;&#227;o ativa deva ser iniciada em condi&#231;&#245;es est&#225;veis, com espera de 24 horas p&#243;s-precordialgia e/ou p&#243;s-cateterismo. Os achados na literatura diferem a respeito do per&#237;odo em que deve ser iniciada a caminhada p&#243;s-evento coronariano agudo, da dist&#226;ncia inicial a ser percorrida e sobre a conveni&#234;ncia da monitoriza&#231;&#227;o de vari&#225;veis circulat&#243;rias nas fases do EG e da caminhada<sup>6-9,11</sup>. No particular, encontramos o estudo de Debusk e cols.<sup>20</sup> que monitoraram a PA na posi&#231;&#227;o sentada e em ortostase, antes de iniciar a caminhada. Recentemente, Nogueira e cols.<sup>21</sup> aplicaram, com sucesso, o teste de caminhada de 6 minutos, na primeira semana p&#243;s-IAM, com o objetivo de avaliar a capacidade funcional. </p>
    <p>Existem poucos dados na literatura sobre a resposta circulat&#243;ria ao EG de pacientes com SCA que vinham em repouso em dec&#250;bito dorsal. Neste estudo, a resposta da PAS e PAD ao EG sentado e em ortostase provocou pequena variabilidade, sugerindo que a maioria desses pacientes, submetidos ao repouso por tempo igual ou superior a 24 horas e ao uso de medica&#231;&#227;o vasodilatadora e betabloqueadora, conservou os seus reflexos posturais ativos, mantendo a integridade do ajuste circulat&#243;rio perif&#233;rico &#224;s mudan&#231;as de posi&#231;&#227;o do corpo<sup>16</sup>. Esse fato sugere uma resposta positiva ao tratamento fisioterap&#234;utico pr&#233;-reabilita&#231;&#227;o, diminuindo o risco de hipotens&#227;o postural p&#243;s-repouso no leito<sup>2</sup>.</p>
    <p>A resposta da FC ao EG sentado e em ortostase mostrou-se adequada, evidenciando a atua&#231;&#227;o fisiol&#243;gica desse sens&#237;vel mecanismo de ajuste &#224;s mudan&#231;as posturais, mediado pelo aumento da atividade simp&#225;tica<sup>22,23</sup>. O resultado desse ajuste fisiol&#243;gico entre as varia&#231;&#245;es da PA e da FC se traduz na leve queda do DP, mantendo est&#225;vel o consumo de oxig&#234;nio mioc&#225;rdio, o que tamb&#233;m se traduz pela estabilidade da SpO<sub>2</sub><sup>22</sup>. Estes dados revelam que a fase de EG na C50m n&#227;o acarreta instabilidade hemodin&#226;mica, desde que os pacientes sejam apropriadamente selecionados e monitorados. Contudo, cerca de &#188; (23,1%) dos pacientes queixaram-se de tontura em resposta ao EG. Embora de leve intensidade, este dado sugere a conveni&#234;ncia de manobras fisioterap&#234;uticas no dec&#250;bito dorsal, na fase pr&#233;-estresse gravitacional, com o objetivo de tentar reduzir esse tipo de queixa, indicadora de que o ajuste gravitacional n&#227;o foi totalmente satisfat&#243;rio.</p>
    <p>A fase de estresse f&#237;sico representada pela C50m mostrou uma resposta cardiovascular positiva, representada pela variabilidade fisiol&#243;gica das vari&#225;veis circulat&#243;rias<sub>, </sub>acionada pelo reflexo auton&#244;mico simp&#225;tico, levando ao aumento do d&#233;bito card&#237;aco, a fim de satisfazer a eleva&#231;&#227;o da demanda muscular emoxig&#234;nio frente ao exerc&#237;cio<sup>13,24</sup>. O grau de varia&#231;&#227;o desses par&#226;metros circulat&#243;rios mostrou que a C50m deflagrou um estresse f&#237;sico apropriado &#224; capacidade funcional desses pacientes, sem repercuss&#227;o cl&#237;nica. Assim, a dura&#231;&#227;o m&#233;dia da C50m mostrou ser o suficiente para avaliar o impacto do exerc&#237;cio sobre o sistema cardiovascular<sup>13,24</sup>, mantendo o esfor&#231;o num limite de baixo risco para essa popula&#231;&#227;o, na fase aguda de um evento coronariano. Corroborando esta assertiva, protocolo recente descreve que a primeira caminhada p&#243;s-evento coronariano deve ser de curta dura&#231;&#227;o, com o tempo m&#233;dio entre 1 a 2 minutos<sup>3</sup>. A resposta fisiol&#243;gica &#224; carga de exerc&#237;cio foi observada no quinto minuto da fase de recupera&#231;&#227;o, quando as vari&#225;veis circulat&#243;rias retornaram a valores pr&#243;ximos aos basais. </p>
    <p>A sensa&#231;&#227;o de desconforto respirat&#243;rio durante a C50m, avaliada pela EB modificada<sup>18</sup>, apresentou poucas modifica&#231;&#245;es em rela&#231;&#227;o &#224; fase pr&#233;-caminhada. Vale salientar, por&#233;m, que essas sensa&#231;&#245;es n&#227;o se fizeram acompanhar de anormalidades hemodin&#226;micas nem da visualiza&#231;&#227;o de desconforto respirat&#243;rio, inspecionado pelo pesquisador. Apenas um paciente (1,6%) referiu estar "ligeiramente cansativo", indicando que a C50m n&#227;o foi um esfor&#231;o f&#237;sico al&#233;m da capacidade cardioventilat&#243;ria. Diante do exposto, o mais prov&#225;vel &#233; que as queixas representassem a apreens&#227;o do paciente frente &#224; mobiliza&#231;&#227;o precoce, apesar do trabalho pr&#233;vio de sensibiliza&#231;&#227;o relativo aos benef&#237;cios da caminhada.</p>
    <p>Dentre os preditores de risco considerados, os sedent&#225;rios, diab&#233;ticos e os indiv&#237;duos com 63 anos ou mais de idade mostraram comportamento da PAS e FC significativamente diverso dos ativos, n&#227;o-diab&#233;ticos e com idade &lt; 63 anos em resposta ao EG e/ou ao estresse f&#237;sico. Esse registro servir&#225; de guia quanto &#224; poss&#237;vel diversidade de comportamento entre esses grupos, permitindo observa&#231;&#227;o mais cuidadosa e poss&#237;veis medidas preventivas quando da aplica&#231;&#227;o da C50m na rotina da RCV1, na UCO. Assim, os pacientes sedent&#225;rios apresentaram aumento da PAS ao estresse gravitacional sentado, resposta esta que pode ser decorrente do baixo condicionamento f&#237;sico<sup>25</sup>. Os diab&#233;ticos apresentaram queda da PAS na assun&#231;&#227;o da posi&#231;&#227;o sentada e maior aumento da FC durante a caminhada, o que pode estar relacionado &#224; neuropatia perif&#233;rica e &#224; desregula&#231;&#227;o auton&#244;mica comum nesses pacientes<sup>26</sup>. Os pacientes com idade <underline>&gt;</underline> 63 anos apresentaram resposta cronotr&#243;pica significativamente menor que aqueles com idade &lt; 63 anos, o que pode ser atribu&#237;do, em parte, &#224; redu&#231;&#227;o fisiol&#243;gica da resposta cronotr&#243;pica do n&#243; sinusal com a idade<sup>27</sup> e ao uso de betabloqueador, o que ocorreu com 63% deles.</p>
    <p>Apesar de n&#227;o haver diferen&#231;a significativa na dura&#231;&#227;o da caminhada entre os grupos, verificou-se, por&#233;m, que a m&#233;dia de tempo mais elevada pertenceu &#224;queles com idade <underline>&gt;</underline> 63 anos e com elevada freq&#252;&#234;ncia de sedentarismo, enquanto o menor tempo foi dos pacientes fisicamente ativos, entre os quais a maioria tinha idade &lt;63 anos. Vale considerar, tamb&#233;m, a redu&#231;&#227;o na capacidade ao exerc&#237;cio com o envelhecimento<sup>27</sup>.</p>
    <p>O comportamento dos pacientes com resposta extrema ao EG sentado revelou resposta diversa ao estresse f&#237;sico. No grupo de pacientes com PAS <underline>&gt;</underline> 142 mmHg, o aumento m&#233;dio da PAS alcan&#231;ou um pico de 160 mmHg, limite de seguran&#231;a no protocolo do estudo<sup>6,8,9</sup>. A FC tamb&#233;m aumentou, com eleva&#231;&#227;o de 7,5 bpm. Esse tipo de resposta sugere um aumento da atividade simp&#225;tica al&#233;m do requerido para o ajuste circulat&#243;rio conseq&#252;ente ao EG e f&#237;sico. Isso pode ter rela&#231;&#227;o com o fato de todos os 13 pacientes terem sobrepeso, com hipertens&#227;o associada em 11, condi&#231;&#245;es que cursam com aumento da atividade simp&#225;tica<sup>13</sup>. Naqueles com PAS&lt; 114 mmHg, todo o ajuste circulat&#243;rio ante o EG sentado e f&#237;sico foi feito pela eleva&#231;&#227;o da FC, com o pico da FC atingindo 95 bpm, pr&#243;ximo ao limite de seguran&#231;a de 100 bpm<sup>6,8,9</sup>; a variabilidade da PAS foi pequena, por&#233;m com tend&#234;ncia &#224; queda. Na an&#225;lise da diversidade de resposta circulat&#243;ria entre esses dois grupos, vale considerar que, dos 16 pacientes com este &#250;ltimo comportamento, 50% tinham IMC normal e 66,3% eram normotensos. Vale o registro do cuidado e da vigil&#226;ncia do risco relativo ao pico da PAS no primeiro grupo e da FC no segundo grupo, no processo da RCV1.</p>
    <p>Apesar de efeitos adversos em cerca de 1/3 dos pacientes, poucos eventos tiveram alguma repercuss&#227;o cl&#237;nica, requerendo a suspens&#227;o do processo de reabilita&#231;&#227;o, o que ocorreu em tr&#234;s (4,8%) deles, nos demais os efeitos foram de leve intensidade, permitindo a execu&#231;&#227;o da caminhada dentro dos crit&#233;rios preestabelecidos. Tontura, que representou a queixa mais freq&#252;ente, foi de pequena intensidade e ocorreu na assun&#231;&#227;o da ortostase, resultante, certamente, da falta de estimula&#231;&#227;o dos reflexos posturais conseq&#252;ente ao repouso no leito<sup>2</sup> e ao uso vasodilatador e betabloqueador. </p>
    <p>A interrup&#231;&#227;o da reabilita&#231;&#227;o em tr&#234;s pacientes obedeceu aos crit&#233;rios seguran&#231;a do protocolo, permitindo pronta recupera&#231;&#227;o dos pacientes.</p>
    <p>
      <bold>Conclus&#245;es</bold>
    </p>
    <p>A C50m pode ser considerada um m&#233;todo bem tolerado de reabilita&#231;&#227;o f&#237;sica para pacientes com SCA, na UTI, a partir de 24 horas p&#243;s-evento, condicionada &#224; observ&#226;ncia dos limites de seguran&#231;a do seu protocolo. S&#227;o condi&#231;&#245;es b&#225;sicas para a sua execu&#231;&#227;o: paciente est&#225;vel, em Killip classe I, liberado pelo cardiologista e bem instru&#237;do pelo fisioterapeuta; al&#233;m disso, &#233; fundamental o controle de PAS, FC e SpO<sub>2</sub> nas suas fases.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi financiado pela Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado da Bahia (FAPESB).</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte da Disserta&#231;&#227;o de Mestrado de Cristiane Maria Carvalho Costa Dias pela Escola Bahiana de Medicina e Sa&#250;de P&#250;blica (EBMSP).</p>
    <p>
      <fn id="end" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Cristiane Maria Carvalho Costa Dias </p>
        <p> Rua da Taquara, 78A, Condom&#237;nio Colina C - Patamares </p>
        <p> 41680-450 - Salvador, BA - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="cristianedias7@yahoo.com.br">cristianedias7@yahoo.com.br</email>
        </p>
      </fn>
    </p>
    <p> Artigo recebido em 19/11/07; revisado recebido em 17/03/08; aceito em 08/04/08.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Mitchell AM, Lown B, Levine SA. The armchair    treatment of acute myocardial infarction. Am J Nurs. 1953; 53 (6): 674-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The armchair treatment of acute myocardial infarction</article-title>
          <source>Am J Nurs</source>
          <date>
            <year>1953</year>
          </date>
          <fpage>674</fpage>
          <lpage>6</lpage>
          <issue>6</issue>
          <volume>53</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mitchell</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Lown</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Convertino VA. Value of orthostatic stress    in maintaining functional status soon after myocardial infarction or cardiac    artery bypass grafting. J Cardiovasc Nurs. 2003; 18 (2): 124-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Value of orthostatic stress in maintaining functional status soon after myocardial infarction or cardiac artery bypass grafting</article-title>
          <source>J Cardiovasc Nurs</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>124</fpage>
          <lpage>30</lpage>
          <issue>2</issue>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Convertino</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. National Heart Foundation of Australia, Australia    Cardiac Rehabilitation Association. Recommended framework for cardiac rehabilitation.    Australia; 2004.</mixed-citation>
        <element-citation publication-type="book">
          <source>Recommended framework for cardiac rehabilitation</source>
          <date>
            <year>2004</year>
          </date>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Stewart KJ, Badenhop D, Brubaker PH, Keteyian    SJ, King M. Cardiac rehabilitation following percutaneous revascularization,    heart transplant, heart valve surgery, and for chronic heart failure. Chest.    2003; 123 (6): 2104-11.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac rehabilitation following percutaneous revascularization, heart transplant, heart valve surgery, and for chronic heart failure</article-title>
          <source>Chest</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2104</fpage>
          <lpage>11</lpage>
          <issue>6</issue>
          <volume>123</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Badenhop</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Brubaker</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Keteyian</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Rehabilitation after cardiovascular diseases,    with special emphasis on developing countries. Report of a WHO Expert Committee.    World Health Organ Tech Rep. 1993; 831: 1-122.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Rehabilitation after cardiovascular diseases, with special emphasis on developing countries: Report of a WHO Expert Committee</article-title>
          <source>World Health Organ Tech Rep</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>1</fpage>
          <lpage>122</lpage>
          <volume>831</volume>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Sociedade Brasileira de Cardiologia. I Consenso    Nacional de Reabilita&#231;&#227;o Cardiovascular. Arq Bras Cardiol. 1997;    69 (4): 267-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>I Consenso Nacional de Reabilita&#231;&#227;o Cardiovascular</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>267</fpage>
          <lpage>91</lpage>
          <issue>4</issue>
          <volume>69</volume>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Ryan TJ, Antman EM. Brooks NH, Califf RM,    Hillis D, Hiratzka LF, et al. and Committee members. 1999 - Update : ACC/AHA-guidelines    for the management of patients whith acute myocardial infarction: executive    summary and recommendations. Circulation. 1999; 100: 1016-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>1999 - Update: ACC/AHA-guidelines for the management of patients whith acute myocardial infarction: executive summary and recommendations</article-title>
          <source>Circulation</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1016</fpage>
          <lpage>30</lpage>
          <volume>100</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ryan</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Antman</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Califf</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Hillis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hiratzka</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Sociedade Brasileira de Cardiologia. Consenso    sobre tratamento no p&#243;s infarto. Arq Bras Cardiol. 1995; 64 (3): 289-96.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Consenso sobre tratamento no p&#243;s infarto</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>289</fpage>
          <lpage>96</lpage>
          <issue>3</issue>
          <volume>64</volume>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Sociedade Brasileira de Cardiologia. II diretrizes    sobre tratamento do infarto agudo do mioc&#225;rdio. Arq Bras Cardiol. 2000;    74 (supl 2): 1-46.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>II diretrizes sobre tratamento do infarto agudo do mioc&#225;rdio</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1</fpage>
          <lpage>46</lpage>
          <volume>74</volume>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Pollock ML, Schmidt DH. (eds.). Doen&#231;a    card&#237;aca e reabilita&#231;&#227;o. 3&#350;. ed. Rio de Janeiro: Revinter;    2003. p. 329-60 </mixed-citation>
        <element-citation publication-type="book">
          <source>Doen&#231;a card&#237;aca e reabilita&#231;&#227;o</source>
          <date>
            <year>2003</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Pollock</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Sociedade Brasileira de Cardiologia. Diretriz    de reabilita&#231;&#227;o card&#237;aca. Arq Bras Cardiol. 2005; 84 (5):    431-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diretriz de reabilita&#231;&#227;o card&#237;aca</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>431</fpage>
          <lpage>40</lpage>
          <issue>5</issue>
          <volume>84</volume>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Karoff M, Held K, Bjarnason-Wehrens B. Cardiac    rehabilitation in Germany. Eur J Cardiovasc Prev Rehabil. 2007; 14 (1): 18-27.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac rehabilitation in Germany</article-title>
          <source>Eur J Cardiovasc Prev Rehabil</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>18</fpage>
          <lpage>27</lpage>
          <issue>1</issue>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Karoff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Held</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bjarnason-Wehrens</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Polito MD, Farinatti PTV. Respostas de freq&#252;&#234;ncia    card&#237;aca, press&#227;o arterial e duplo produto ao exerc&#237;cio    contra-resistente: uma revis&#227;o da literatura. Revista Portuguesa de Ci&#234;ncias    do Desporto. 2003; 3 (1): 79-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Respostas de freq&#252;&#234;ncia card&#237;aca, press&#227;o arterial e duplo produto ao exerc&#237;cio contra-resistente: uma revis&#227;o da literatura</article-title>
          <source>Revista Portuguesa de Ci&#234;ncias do Desporto</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>79</fpage>
          <lpage>91</lpage>
          <issue>1</issue>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Polito</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Farinatti</surname>
              <given-names>PTV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Luukinen H, Koski K, Laippala P, Kivela SL.    Prognosis of diastolic and systolic orthostatic hypotension in older persons.    Arch Intern Med. 1999; 159: 273-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prognosis of diastolic and systolic orthostatic hypotension in older persons</article-title>
          <source>Arch Intern Med</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>273</fpage>
          <lpage>80</lpage>
          <volume>159</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Luukinen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Koski</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Laippala</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kivela</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. James MA, Potter JF. Orthostatic blood pressure    changes and arterial baroreflex sensitivity in elderly subjects. Age Ageing.    1999; 28 (6): 522-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Orthostatic blood pressure changes and arterial baroreflex sensitivity in elderly subjects</article-title>
          <source>Age Ageing</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>522</fpage>
          <lpage>30</lpage>
          <issue>6</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>James</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Potter</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Netea RT, Smits P, Lenders JW, Thien T. Does    it matter whether blood pressure measurements are taken with subjects sitting    or supine? J Hypertens. 1998; 16 (3): 263-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Does it matter whether blood pressure measurements are taken with subjects sitting or supine?</article-title>
          <source>J Hypertens</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>263</fpage>
          <lpage>8</lpage>
          <issue>3</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Netea</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Smits</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lenders</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Thien</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Sociedade Brasileira de Cardiologia. IV Diretrizes    brasileiras de hipertens&#227;o arterial. Arq Bras Cardiol. 2004; 82 (supl.    4): 7-14.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>IV Diretrizes brasileiras de hipertens&#227;o arterial</article-title>
          <source>Arq Bras Cardiol.</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>7</fpage>
          <lpage>14</lpage>
          <volume>82</volume>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Iserin L, Chua TP, Chambers J, Coats AJ,    Somerville J. Dyspnoea and exercise intolerance during cardiopulmonary exercise    testing in patients with univentricular heart: the effects of chronic hypoxaemia    and Fontan procedure. Eur Heart J. 1997; 18 (8): 1350-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Dyspnoea and exercise intolerance during cardiopulmonary exercise testing in patients with univentricular heart: the effects of chronic hypoxaemia and Fontan procedure</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1350</fpage>
          <lpage>6</lpage>
          <issue>8</issue>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Iserin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chua</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Chambers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coats</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Somerville</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Hulley SB, Cummings SR, Browner WS. Delineando    a pesquisa cl&#237;nica: uma abordagem epidemiol&#243;gica. 2&#350; ed. Porto    Alegre: Artmed; 2003. p. 86-99.</mixed-citation>
        <element-citation publication-type="book">
          <source>Delineando a pesquisa cl&#237;nica: uma abordagem epidemiol&#243;gica</source>
          <date>
            <year>2003</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Hulley</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Browner</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Debusk RF, Blomqvist CG, Kouchoukos NT, Luepker    RV, Miller HS, Moss AJ, et al. Identification and treatment of low-risk patients    after acute myocardial infarction and coronary artery bypass graft surgery.    N Engl J Med. 1986; 314: 161-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Identification and treatment of low-risk patients after acute myocardial infarction and coronary artery bypass graft surgery</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1986</year>
          </date>
          <fpage>161</fpage>
          <lpage>6</lpage>
          <volume>314</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Debusk</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Blomqvist</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Kouchoukos</surname>
              <given-names>NT</given-names>
            </name>
            <name>
              <surname>Luepker</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Nogueira PA, Leal AC, Pulz C, Nogueira ID,    Filho JA. Clinical realiability of the 6 minute corridor walk test performed    within a week of a myocardial infarction. Int Heart J. 2006; 47: 533-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Clinical realiability of the 6 minute corridor walk test performed within a week of a myocardial infarction</article-title>
          <source>Int Heart J</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>533</fpage>
          <lpage>40</lpage>
          <volume>47</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nogueira</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Leal</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Pulz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nogueira</surname>
              <given-names>ID</given-names>
            </name>
            <name>
              <surname>Filho</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Jones AY, Dean E. Body position change and    its effect on hemodynamic and metabolic status. Heart Lung. 2004; 33 (5): 281-90.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Body position change and its effect on hemodynamic and metabolic status</article-title>
          <source>Heart Lung</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>281</fpage>
          <lpage>90</lpage>
          <issue>5</issue>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Dean</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara    A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction    of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone    and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998; 351 (9101):    478-84.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators</article-title>
          <source>Lancet</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>478</fpage>
          <lpage>84</lpage>
          <issue>9101</issue>
          <volume>351</volume>
          <person-group person-group-type="author">
            <name>
              <surname>La Rovere</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Bigger Jr</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Marcus</surname>
              <given-names>FI</given-names>
            </name>
            <name>
              <surname>Mortara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Kawamura T. Avalia&#231;&#227;o da capacidade    f&#237;sica e teste ergom&#233;trico. Rev Soc Cardiol Estado de S&#227;o    Paulo. 2001; 11 (3): 659-72.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Avalia&#231;&#227;o da capacidade f&#237;sica e teste ergom&#233;trico</article-title>
          <source>Rev Soc Cardiol Estado de S&#227;o Paulo</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>659</fpage>
          <lpage>72</lpage>
          <issue>3</issue>
          <volume>11</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kawamura</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Church TS, Earnest CP, Skinner JS, Blair    SN. Effects of different doses of physical activity on cardiorespiratory fitness    among sedentary, overweight or obese postmenopausal women with elevated blood    pressure: a randomized controlled trial. JAMA. 2007; 297: 2081-91.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial</article-title>
          <source>JAMA</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>2081</fpage>
          <lpage>91</lpage>
          <volume>297</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Church</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Earnest</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Skinner</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Blair</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Vinik AI, Ziegler D. Diabetic cardiovascular    autonomic neuropathy. Circulation. 2007; 115 (3): 387-97.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diabetic cardiovascular autonomic neuropathy</article-title>
          <source>Circulation</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>387</fpage>
          <lpage>97</lpage>
          <issue>3</issue>
          <volume>115</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Vinik</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Ziegler</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Oliveira JLM, Paix&#227;o BA, Silva AAB,    Barreto AM, Souza ACS. Incompet&#234;ncia cronot&#243;pica em idosos prediz    altera&#231;&#245;es segmentares &#224; ecocardiografia sob estresse pelo    esfor&#231;o f&#237;sico. Rev Bras Ecocardiogr. 2005; 18: 23-30.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Incompet&#234;ncia cronot&#243;pica em idosos prediz altera&#231;&#245;es segmentares &#224; ecocardiografia sob estresse pelo esfor&#231;o f&#237;sico</article-title>
          <source>Rev Bras Ecocardiogr</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>23</fpage>
          <lpage>30</lpage>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>JLM</given-names>
            </name>
            <name>
              <surname>Paix&#227;o</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>AAB</given-names>
            </name>
            <name>
              <surname>Barreto</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>ACS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Circulatory response to a 50-m walk in the coronary care unit in acute coronary syndrome</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Lack of a standardized and monitored technique to start rehabilitation of patients with acute coronary syndrome (ACS) in the coronary care unit. OBJECTIVE: To describe the technique of and circulatory response to a 50-m walk (W50m). METHODS: Experimental cross-sectional study of 65 patients with ACS; of these, 36 (54%) with acute myocardial infarction (AMI), Killip I, 29 (45.2%) with unstable angina (UA), 61.5% males with age of 62.8 &#177; 12.7 years. Walk was started 45&#177;23h after hospitalization. Parameters measured: systolic blood pressure (SBP mmHg), diastolic blood pressure (DBP mmHg), heart rate (HR bpm), double product (SBP mmHg X HR bpm), peripheral oxygen saturation (SpO2%), walking time, and exercise tolerance by Borg scale (BS). Measurements were taken while supine, sitting, in orthostasis (phase 1 [gravitational stress]), end of the walk, and after a 5-minute rest (phase 2 [exercise stress]). RESULTS: Increased HR in response to the sitting gravitational stress (&#916;=4.18) and with orthostasis (&#916;=2.69) (p&lt;0.001) was observed. At the end of walk, there was an elevation in SBP (&#916;=4.84), (p&lt;0.001), HR (&#916;=4.68), (p&lt;0.001) and DP (&#916;=344.97), (p=0.004), and a reduction in SpO2 (&#916;=-1.42), (p&lt;0.001), with return to baseline values after 5 minutes. Walking time was 2'36"&#177;1'17", and exercise tolerance by BS was good. SBP response &gt; 142 mmHg when sitting was associated with a significant increase (p=0.031) of 11 mmHg at exercise in 13 patients with overweight/obesity and 85% with hypertension. Adverse effects occurred in 19 (29.2%) patients and dizziness in 23.1%, which impaired the walk in three of them. CONCLUSION: In this sample, patients did not present severe collateral effects to W50m. 24 hours after a coronary event.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Myocardial infarction</kwd>
        <kwd>unstable angina</kwd>
        <kwd>rehabilitation</kwd>
        <kwd>motor activity</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p><undefined id="tx-body2"/>Circulatory response to a 50-m walk in the coronary care unit in acute coronary syndrome</p>
      <p>
        <bold>Cristiane Maria Carvalho Costa Dias; Ana C&#233;lia Carneiro de Almeida Maiato; K&#225;tia Maria Moreno Baqueiro; Alessandra Maia Furtado Fiqueredo; Fernanda Warken Rosa; Janaina Oliveira Pitanga; Ludmila Ivo Cat&#227;o de Souza; Arm&#234;nio Costa Guimar&#227;es</bold>
      </p>
      <p>Escola Bahiana de Medicina e Sa&#250;de P&#250;blica (EBMSP), Hospital Alian&#231;a (HA), Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado da Bahia (Fapesb), Salvador, BA - Brazil</p>
      <p>Mailing address </p>
      <p>
        <bold>SUMMARY</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Lack of a standardized and monitored technique to start rehabilitation of patients with acute coronary syndrome (ACS) in the coronary care unit.</p>
      <p><bold>OBJECTIVE:</bold> To describe the technique of and circulatory response to a 50-m walk (W50m).</p>
      <p><bold>METHODS: </bold> Experimental cross-sectional study of 65 patients with ACS; of these, 36 (54%) with acute myocardial infarction (AMI), Killip I, 29 (45.2%) with unstable angina (UA), 61.5% males with age of 62.8 &#177; 12.7 years. Walk was started 45&#177;23h after hospitalization. Parameters measured: systolic blood pressure (SBP mmHg), diastolic blood pressure (DBP mmHg), heart rate (HR bpm), double product (SBP mmHg X HR bpm), peripheral oxygen saturation (SpO<sub>2</sub>%), walking time, and exercise tolerance by Borg scale (BS). Measurements were taken while supine, sitting, in orthostasis (phase 1 [gravitational stress]), end of the walk, and after a 5-minute rest (phase 2 [exercise stress]).</p>
      <p><bold>RESULTS: </bold> Increased HR in response to the sitting gravitational stress (&#916;=4.18) and with orthostasis (&#916;=2.69) (p&lt;0.001) was observed. At the end of walk, there was an elevation in SBP (&#916;=4.84), (p&lt;0.001), HR (&#916;=4.68), (p&lt;0.001) and DP (&#916;=344.97), (p=0.004), and a reduction in SpO<sub>2</sub> (&#916;=-1.42), (p&lt;0.001), with return to baseline values after 5 minutes. Walking time was 2'36"&#177;1'17", and exercise tolerance by BS was good. SBP response <underline>&gt;</underline> 142 mmHg when sitting was associated with a significant increase (p=0.031) of 11 mmHg at exercise in 13 patients with overweight/obesity and 85% with hypertension. Adverse effects occurred in 19 (29.2%) patients and dizziness in 23.1%, which impaired the walk in three of them.</p>
      <p><bold>CONCLUSION:</bold> In this sample, patients did not present severe collateral effects to W50m. 24 hours after a coronary event. </p>
      <p><bold>Key words:</bold> Myocardial infarction; unstable angina; rehabilitation; motor activity.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Early physical rehabilitation of patients with acute cardiac events started with the "armchair treatment" proposed by Mitchell et al<sup>1</sup> in Boston, in 1953, for patients with AMI. The objective was to reduce pulmonary, embolic, autonomic and neuromuscular complications resulting from bed rest, which extended for three to six weeks<sup>1</sup>. In 2003, Convertino described that prolonged bed rest after AMI and angioplasty were not uncommon, mainly in the Coronary Care Unit (CCU). He warned about the frequency of orthostatic intolerance and reflex tachycardia, which are common adverse effects in these patients when they assume the standing position<sup>2</sup>. The mobilization program should be balanced between the risk of early mobilization and the harmful effects secondary to bed rest<sup>3</sup>.</p>
      <p>The practice of in-hospital-phase cardiovascular rehabilitation (CVR1) was introduced in the CCU, applicable to ACS<sup>2,4-9</sup>, and starting from 12 to 24 h post-event, if possible<sup>3,7</sup>. Most of the protocols indicate gravitational stress (GS) and walk as components of the CVR1<sup>7-12</sup>; however, there is no consensus as regards the monitoring of the circulatory response that translates the degree of stress imposed to the cardiovascular system<sup>13</sup> by the distance and walking time. </p>
      <p>Another point of concern is the failure to warn the interdisciplinary team members on the heterogeneity of this population, which has several associated risk factors<sup>3</sup> that can potentially trigger complications during GS and walk. Based on the empirical practice of CVR1 in a CCU, we sought to describe the technique of W50m in its physical and GS phases according to the circulatory response, thus permitting a more rational and safe CVR1 programming.</p>
      <p>
        <bold>Material/Methods</bold>
      </p>
      <p>Experimental cross-sectional study conducted in the CCU of a private hospital in the city of Salvador, BA, Brazil, from April 2006 to January 2007. Patients with ACS who had medical permission to walk, who had not undergone surgical myocardial revascularization, and were oriented to time and space were included in the study. Patients who had medical permission to walk but refused to give their informed consent, and those who had any condition, such as chest pain, dyspnea, paroxysmal arrhythmia, acute ST-segment and T-wave alterations, baseline HR &gt; 100 bpm, SpO<sub>2</sub> &lt; 92%; 100&lt;SBP &gt; 160 mmHg and DBP &gt;100 mmHg<sup>6</sup>, that could put them at risk at the moment of the W50m were excluded.</p>
      <p>During collection, 94 patients diagnosed with ACS were recruited; 23 were excluded according to the exclusion criteria, one patient dropped and five refused to participate. The sample was comprised of 65 patients whose main clinical and demographic characteristics are shown in <xref ref-type="table" rid="tab01-body2">Table 1</xref>. Of these, 36 (54.8%) had AMI, 24 (36.9%) non-ST-segment elevation and 12 (18.5%) ST-segment elevation, and 29 (45.2%) had UA; the male gender predominated, with 40 patients (61.5%), and the mean age was 62.8 &#177;12.7 years (ranging from 38 to 94 years); the majority of the patients (30 &#150; 46.2%) had a higher education level, and five (7.7%) were illiterate or had not completed the basic school course; 38 (58.5%) were economically active.</p>
      <table-wrap id="tab01-body2">
        <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt01-en.jpg"/></table-wrap>
      <p>The most frequent associated risk factors were: sedentary lifestyle (76.9%); overweight / obesity (69.2%); male gender (61.5%) and hypertension (63.1%). The mean BMI was elevated (27&#177;4.0 Kg/m<sup>2</sup>) in the overweight / obesity range. Coronary angiography performed in 47 patients (72.3%) revealed stenosis <underline>&gt;</underline>70%, one-vessel disease in 11 patients (16.9%), two-vessel disease in 12 patients (18.3%) and three-vessel disease in 8 (12.3%), with nine patients (13.8%) being treated with angioplasty. Vasodilator was used in 52 patients (80%), and beta-blocker in 47 (72.3%).</p>
      <p>The research was approved by the Research Ethics Committee of <italic>Escola Bahiana de Medicina</italic> (CEP: 75/2005).</p>
      <p>
        <bold>50-m walk</bold>
      </p>
      <p>The 50-m distance represented the usual trajectory of the patients in their first post-event walk, which is already performed in the CCU routine, with the physical therapist. The variables chosen for monitoring represented the main indicators of the activity of the heart as a pump, and of the regulation of blood circulation hemodynamics: HR, SBP, DBP, double product (DB) as an indirect reflex of myocardial oxygen consumption, and SpO<sub>2</sub>, as a reflex of the peripheral oxygen extraction. The BS complemented the subjective assessment of the response to stress induced by walking. </p>
      <p>The circulatory response to W50m was monitored in two phases: Phase 1 &#150; supine position at 0&#186;, sitting on the bed with the legs hanging, and with orthostasis; Phase 2 &#150; after three minutes in the standing position<sup>14</sup>, during and at the end of the walk, and in the recovery phase and after 5 minutes<sup>15-16</sup>.</p>
      <p>All patients underwent clinical assessment, with recording of their clinical and anthropometric data. A W-200 (Welmi - Brazil) anthropometric scale was used to measure weight and height. Body mass index was calculated by the Quetelet index: BMI = Weight in Kg/height in m<sup>2</sup>.</p>
      <p>Blood pressure (BP) was measured according to the IV Brazilian Guidelines on Hypertension<sup>17</sup>, using the auscultation technique, with a Missouri (Mikatos-Brazil) tensiometer aneroid sphygmomanometer. HR was measured with a Polar (Electro OY - Finland) device, and SpO<sub>2</sub> with a 1001 (Moriya-Brazil) portable pulse oximeter. The walking duration was measured using a Ferrari (Oregon - USA) chronometer. Measurement of the circulatory variables followed this sequence: BP after 5 minutes in the supine position at 0<sup>&#186;</sup>, within the first minute after sitting down, at the first and third minutes after standing up, at the first minute at the end of the walk, and at the fifth minute of recovery; HR and SpO<sub>2 </sub>were monitored continuously, with the values being recorded at the beginning of BP measurement.</p>
      <p>At the beginning of the walk, the patients were questioned whether they were feeling any type of discomfort, whether they were willing to perform the walk, and were advised to stop the walk in case of any type of discomfort. The modified BS (0-10) was used because it is the most up-to-date scale<sup>18</sup>. It was administered at the beginning and at the end of the walk, and the patients were advised not to go beyond level four (slightly tiring), which is the maximum safety limit for physical activity in this phase<sup>6</sup>. W50m was supervised by the physical therapist who recorded HR<sub>max</sub> and SpO<sub>2min</sub>; no verbal stimulus was given regarding the walking pace and speed. The patients determined their own pace; at the end of the walk, the circulatory parameters and BS score were recorded.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>
        <bold>Sample size calculation</bold>
      </p>
      <p>Sample size calculation was based on the HR endpoint, which is considered an indicator of the patient's functional response. The alternative hypothesis to be tested was that HR would increase with the W50m physical stress, and the magnitude of this effect (E) was estimated at +4bpm, thus characterizing a one-way analysis. The endpoint variability (HR elevation), in turn, was estimated with base on the standard deviation (S) of the mean HR, which was calculated as &#188; of a HR variation from 70 to 100 bpm (considering that many of these patients were on beta-blockers): thus SD = 30&#247;4= &#177;7.5 bpm. The magnitude of the standardized amplitude of the effect (E/S), defined by the quotient of the total interval amplitude (4) by SD (7.5): 4&#247;7.5 = 0.53 was then calculated. In light of these values and for &#945;=0.05 (significance level) and &#946;=0.20 (study power), an N value of 51 patients was found, which, added by 20% to compensate losses, reached a minimum of 62 patients<sup>19</sup>.</p>
      <p>The independent variables were: gender, age, physical activity, BMI, type of ACS, dyslipidemia, hypertension, diabetes, smoking, and use of vasodilator and beta-blocker. The dependent variables were: SBP, DBP, HR, DP, SpO<sub>2</sub>, BS, and walking duration. The database and the descriptive and analytical analysis were performed with the Statistical Package for Social Sciences (SPSS) software, version 12.0 for Windows. The Kolmogorov-Smirnov test was used to analyze the normality of continuous variables distribution. </p>
      <p>Categorical variables were expressed as percentage values (%); continuous variables with normal distribution, as mean and standard deviation (X &#177; SD); and variables with asymmetrical distribution, as median and interquartile interval. </p>
      <p>The chi-square test was used for comparison of the categorical variables; when this test proved inappropriate, the Fischer test was used. The McNemar test was used for the comparative analysis of BS (pre and post).</p>
      <p>The statistical significance of the difference between the means of variables in the GS and walk phases was set using the Student's t test for paired samples. The comparison of these variables between the risk predictors was made using the Student's t test for independent samples. When appropriate, these comparisons were made using the Wilcoxon U and T tests, respectively. The significance level was set at 5%.</p>
      <p>The study was sponsored by <italic>Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado da Bahia.</italic></p>
      <p>
        <bold>Results</bold>
      </p>
      <p>
        <bold>50-m walk</bold>
      </p>
      <p>W50m was administered 45.0 &#177; 23.0 hours after hospital admission, ranging from 24 to 48 hours in 27 (41.5%) patients, 10 (27.8%) of whom had AMI; from 48 to 72 hours in 33 (50.8%) patients, and from 96 to 120 hours in four (6.2%); only one patient performed the test on the fifth day of admission. The time of administration varied according to the moment of the last anginal attack and of catheterization and/or angioplasty, with a waiting time of approximately 24 hours.</p>
      <p>
        <bold>Behavior of circulatory variables and W50m duration</bold>
      </p>
      <p>Mean baseline values of the circulatory variables studied, as measured in the supine position at 0&#186;, were: SBP 128.8 &#177;15.0 mmHg; DBP 73.8 &#177;12.5 mmHg; HR 70.9&#177;10.4 bpm; DP 10.007 &#177; 77.07 mmHgXbpm; and SpO<sub>2 </sub>95&#177;2.0 %, which are normal values. Change from the supine position at 0<sup>&#186;</sup> to the sitting position and then to the standing position led to a significant elevation of HR, &#916;+4.18 bpm (p&lt;0.001) and &#916; +2.69bpm (p&lt;0.001), respectively, however with no clinical consequences (<xref ref-type="table" rid="tab02-body2">Table 2</xref>).</p>
      <table-wrap id="tab02-body2">
        <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt02-en.jpg"/></table-wrap>
      <p>At the end of the walk, increased levels of SBP, &#916; +4.84 mmHg (p&lt;0.001), HR, &#916; +4.68 bpm (p&lt;0.001), and DP, &#916; +344.97mmHgxbpm (p=0.004), as well as decreased levels of SpO<sub>2</sub>&#916; -1.42% (p&lt;0.001) were observed, and all these values were significant, however with no clinical consequences. In the recovery phase, after five minutes in the sitting position, the variables studied showed a significant reduction (SBP, &#916; -4.53 mmHg, p&lt;0.024, HR, &#916; -9.06 bpm, DP, &#916; - 869.42mmHgxbpm, p&lt;0.001 and DBP, &#916; -3.14mmHg, p=0.006), except for SpO<sub>2 </sub>which showed a significant increase, &#916;+2.16%, p&lt;0.001, and all returned to baseline levels rapidly (<xref ref-type="table" rid="tab02-body2">Table 2</xref>). The mean W50m duration was 2.5&#177;1.3 min.</p>
      <p>Perception of the physical and GS phases by BS revealed a rightward deviation in relation to baseline scores. In the pre-walk phase, 33 (53.2%) individuals reported "no dyspnea" (score 0), 27 (43.5%) reported "very very mild" and from "very mild to mild" dyspnea (score from 0.5 to 2) and two (3.2%) "moderate" dyspnea (score 3). At the end of the walk, the distribution of these scores was 25 (40.3%), 29 (46.8%) and seven (11.3%), respectively, with one additional patient (1.6%) whose dyspnea became more intense (score 4). This patient had UA; she was 64 years old, smoker and obese.</p>
      <p>
        <bold>Variation of the circulatory variables among the risk predictors</bold>
      </p>
      <p>GS of the sitting position from the supine position at 0<sup>&#186;</sup> led to a statistically significant divergent variation of &#916; SBP, however with no clinical consequences both in sedentary and in diabetic individuals. In sedentary individuals, there was an elevation of &#916; SBP by +1.68 mmHg, whereas in physically active individuals there was a reduction by -4.71 mmHg (p=0.030) (<xref ref-type="table" rid="tab03-body2">Table 3</xref>). In diabetics, there was a &#916;SBP reduction by -3.5 mmHg, whereas in non-diabetics there was an elevation by +2 mmHg (p=0.012) (<xref ref-type="table" rid="tab03-body2">Table 3</xref>). HR variation was positive in all patients, including those on beta-blockers. </p>
      <table-wrap id="tab03-body2">
        <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt03-en.jpg"/></table-wrap>
      <p>In relation to the GS with orthostasis, no significant variation in SBP was observed, but there was a significant variation of the HR behavior among patients with age lower than or equal to 63 years (median age of the sample), however with no clinical consequences. Individuals with age <underline>&gt;</underline> 63 years presented a &#916; HR of +0.73 bpm, versus an increase by +4.72 bpm in patients with age &lt; 63 years, p=0.002 (<xref ref-type="table" rid="tab03-body2">Table 3</xref>).</p>
      <p> After physical stress, the &#916;SBP in diabetics was 2.17 mmHg, whereas in non-diabetics it was 6.41 mmHg, with a p value very close to the significance value (0.061). On the other hand, in diabetics, the &#916;HR was +8.39 bpm, which was significantly higher than in non-diabetics (&#916;HR +2.49 bpm, p=0.017) (<xref ref-type="table" rid="tab03-body2">Table 3</xref>). With the use of beta-blockers, there was a change in HR and SBP, however with no statistical or clinical significance. As for the duration, W50m did not show any significant difference among the risk predictors. However, those with age <underline>&gt;</underline> 63 years had the highest mean W50m duration, of 2 min 52s &#177; 1.37, <italic>versus</italic> those physically active who had the lowest mean, of 1 min 98s &#177;0.80.</p>
      <p>
        <bold>Behavior of extreme values in response to W50m</bold>
      </p>
      <p>The group who presented SBP values <underline>&gt;</underline> 142 mmHg when sitting showed a significant elevation of &#916;SBP by +2.00 mmHg (p=0.013) in relation to the supine position at 0<sup>&#186;</sup>, with maximum SBP value of 154 mmHg; after W50m the &#916;SBP increased by +11mmHg, p=0.013, with a maximum SBP value of 160 mmHg. During recovery, the &#916;SBP was -3 mmHg, not significant, and the maximum SBP dropped to 153 mmHg (<xref ref-type="table" rid="tab04-body2">Table 4</xref>). There was a significant elevation of HR when sitting, with &#916;HR of +4.00 bpm, p= 0.004, peak of 80 bpm, and after walk, &#916;HR of +3.5 bpm, p&lt; 0.001, peak of 81bpm, with a significant reduction in the recovery phase (&#916;HR-6.50 bpm, p=0.017), peak of 75 bpm (<xref ref-type="table" rid="tab04-body2">Table 4</xref>). In patients who presented SBP <underline>&lt;</underline> 114 mmHg when sitting, SBP remained stable, whereas there was a significant HR elevation (&#916;HR +4.5 bpm, p=0.004) when sitting, with orthostasis (&#916;HR +3.0 bpm, p=0.013), and after walk (&#916;HR +5.0 bpm, p=0.014), with a cumulative increase by 12.5 bpm and peak of 95 bpm during walk. In the recovery phase, there was a significant deceleration by 10 bpm (p=0.001), and the peak HR dropped to 88 bpm (<xref ref-type="table" rid="tab04-body2">Table 4</xref>).</p>
      <table-wrap id="tab04-body2">
        <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt04-en.jpg"/></table-wrap>
      <p>Among the risk predictors analyzed, all 13 (100.0%) patients who had an extreme response with SBP <underline>&gt;</underline> 142 mmHg were overweight / obese, when compared with the eight (50.0%) of the 16 patients with extreme SBP response <underline>&lt;</underline> 114 mmHg, p=0.030, and 11 patients (85.0%) were hypertensive versus 7 (44.0%), respectively, p=0.0524.</p>
      <p>
        <bold>Adverse effects to the 50-m walk</bold>
      </p>
      <p>Adverse effects were observed in the GS phase of orthostasis in 19 patients (29.2%); the most frequent was dizziness, occurring in 15 patients (23.1%), followed by orthostatic hypotension in four (6.3%). Except for three patients for whom the walk had to be interrupted, one patient presented chest pain, another presented increased blood pressure (BP=168X110mmHg) and the third had hypotension with dizziness (BP=100X88mmHg, with &#916;SBP=-18 mmHg). All three patients presented profuse sweating and were on beta-blockers and vasodilators. </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The present study describes the behavior of circulatory variables to W50m in patients with ACS in the CCU, in compliance with the BSC Guideline, which recommends in-hospital cardiovascular rehabilitation for patients with this clinical profile<sup>6,8,9,11</sup>. However, for a successful rehabilitation, the circulatory response has to be monitored, as was done in this study. </p>
      <p>Associated risk factors are common among patients with this type of condition, as demonstrated by the high percentage of sedentary lifestyle, overweight / obesity, hypertension and diabetes, and this is an additional risk for the administration of W50m. This fact shows the importance of the standardization and monitoring of the impact of physical and GS of W50m on the cardiovascular system, as a means to ensure an early rehabilitation process. Considering the pathophysiological changes resulting from bed rest, the literature shows the importance of increasing GS and walk as soon as possible<sup>2</sup>. However, this is only indicated for patients with stable ACS<sup>6,8,9,11</sup>.</p>
      <p>The mean W50m administration time reflects the caution to be taken that active rehabilitation should be started in stable conditions, with a 24-h wait after chest pain and/or catheterization. The findings in the literature are discrepant as regards the period in which walking should be started after an acute coronary event, the initial distance to walk, and the convenience of circulatory variables monitoring in the GS and walk phases<sup>6-9,11</sup>. In this particular, we found Debusk et al's study (1986) which monitored BP in the sitting and standing positions before starting the walk<sup>20</sup>, and, more recently, Nogueira et al<sup>21</sup> study in which the 6-minute walk test was successfully performed in the first week post-AMI with the objective of assessing the functional capacity. </p>
      <p>Few data on the circulatory response to GS of patients with ACS who had been at rest in the supine position are available in the literature. In this study, the response of SBP and DBP to GS in the sitting and standing positions showed a small variation, thus suggesting that the majority of these patients when undergoing rest for 24 hours or longer and taking vasodilators and beta-blockers had maintained their postural reflexes active; the integrity of the peripheral circulatory adjustment to body position changes was also maintained<sup>16</sup>. This fact suggests a positive response to the pre-rehabilitation physical therapy, with a reduction of the risk of orthostatic hypotension after bed rest<sup>2</sup>.</p>
      <p>HR response to GS in the sitting and standing positions was adequate, thus showing the physiological performance of this sensitive mechanism of adjustment to body position changes mediated by an increase in the sympathetic activity<sup>22,23</sup>. The result of this physiological adjustment between the BP and HR variables is a mild reduction of DP, with the myocardial oxygen consumption kept stable, which is also demonstrated by the SpO<sub>2</sub> stability<sup>22</sup>. These data reveal that the GS phase to W50m does not lead to hemodynamic instability, provided that the patients are appropriately selected and monitored. However, approximately &#188; (23.1%) of the patients reported dizziness in response to GS. Although mild, this finding suggests that physical therapeutic maneuvers in the supine position are adequate during the pre-gravitational stress phase with the purpose of reducing the frequency of this type of complaint, which indicates that the gravitational adjustment was not fully satisfactory.</p>
      <p>The physical stress phase represented by W50m showed a positive cardiovascular response, as demonstrated by the physiological variation of the circulatory variables triggered by the sympathetic autonomic reflex leading to increased cardiac output in order to meet the increased muscle oxygen demand in response to exercise<sup>13,24</sup>. The degree of variation of these circulatory parameters showed that W50m triggered a physical stress appropriate to the functional capacity of these patients, with no clinical consequences. Thus, the mean W50m duration proved to be enough to assess the impact of exercise on the cardiovascular system<sup>13,24</sup>, maintaining exertion at a low-risk limit for this population in the acute phase of a coronary event. In corroboration to this statement, a recent protocol describes that the first walk after a coronary event should be short, with a mean duration between one and two minutes<sup>3</sup>. The physiological response to the exercise load was observed in the fifth minute of the recovery phase, when the values of the circulatory variables returned to values close to baseline.</p>
      <p>The sensation of respiratory discomfort during W50m, as assessed by the modified BS<sup>18</sup>, showed little changes in relation to the pre-walk phase. However, it is worth pointing out that these sensations were neither accompanied by hemodynamic abnormalities nor by the finding of respiratory discomfort as examined by the researcher. Only one patient (1.6%) reported mild tiredness, thus indicating that W50m was not a physical exertion beyond the patients' cardiorespiratory capacity. Therefore, the complaints more likely represented the patients' apprehension about early mobilization, despite the previous briefing on the benefits of walking.</p>
      <p>Among the risk predictors analyzed, patients with a sedentary lifestyle, diabetes, and age equal to or higher than 63 years showed a SBP and HR behavior significantly different from that of active, non-diabetic patients with age &lt; 63 years in response to GS and/or physical stress. This finding may be a reference as to the possible behavioral differences between these groups, thus allowing a more careful observation and possible preventive measures when W50m is performed in the routine of CVR1 in the CCU. Thus, sedentary patients showed increased SBP to gravitational stress in the sitting position, a response that may be due to a poor physical fitness<sup>25</sup>. Diabetics showed decreased SBP when assuming the sitting position and a greater HR elevation during walk, which can be related to the neuropathy and dysautonomia that are common in these patients<sup>26</sup>. Patients with age <underline>&gt;</underline> 63 years had a significantly lower chronotropic response than those with age &lt; 63 years, which may be partly attributed to the physiological reduction in the chronotropic response of the sinus node with age<sup>27</sup>, and to the use of beta-blockers, which occurred with 63% of the patients. </p>
      <p>Although there was no significant difference in walk duration between the groups, we could observe that the mean time was higher among those with age <underline>&gt;</underline> 63 years and high frequency of sedentary lifestyle, whereas the shortest time was observed among physically active patients, the majority of whom were &lt; 63 years old. The reduction in exercise capacity with aging should also be considered<sup>27</sup>.</p>
      <p>The behavior of patients with extreme responses to GS in the sitting position revealed different responses to physical stress. In the group of patients with SBP<underline>&gt;</underline>142 mmHg, the mean SBP elevation reached a peak of 160mmHg, which was the safety limit of the study protocol<sup>6,8,9</sup>. The HR also increased by 7.5 bpm. This type of response suggests an increased sympathetic activity beyond that required for the circulatory adjustment resulting from physical and GS. This can be related to the fact that all 13 patients were overweight, and 11 had associated hypertension, and these conditions are accompanied by increased sympathetic activity<sup>13</sup>. In the patients with SBP &lt; 114 mmHg, all the circulatory adjustment in response to GS in the sitting position and physical stress was made through HR elevation, with the peak HR reaching 95 bpm, close to the safety limit of 100 bpm<sup>6,8,9</sup>. SBP variation was low, however with a downward trend. In the analysis of the different circulatory responses between these two groups, it is worth considering that of the 16 patients with the latter behavior, 50% had normal BMI and 66.3% were normotensive. We should point out the care and surveillance of the relative risk to the SBP peak required in the first group, and of HR in the second group, in the process of CVR1.</p>
      <p>Despite the occurrence of adverse effects in approximately 1/3 of the patients, few events had any clinical consequence that required interruption of the rehabilitation process, which occurred in three (4.8%) of them. In the remaining patients, the effects were mild, thus permitting that the walk was performed within the pre-established criteria. Dizziness, which was the most frequent complaint, was mild and occurred when assuming the standing position, thus certainly resulting from a lack of stimulation of the postural reflexes due to bed rest<sup>2</sup> and to the use of vasodilators and beta-blockers.</p>
      <p>Interruption of rehabilitation in three patients followed the safety criteria of the protocol, and permitted a ready recovery of the patients.</p>
      <p>
        <bold>Conclusions</bold>
      </p>
      <p>W50m may be considered a well-tolerated physical rehabilitation method for patients with ACS in the ICU, as from 24h post-event, provided that the safety limits of the protocol are observed. Basic conditions for its performance are that the patient be stable, in Killip class I, has a cardiologist's permission, is well instructed by the physical therapist, and SBP, HR and SpO<sub>2 </sub>are monitored in the different phases.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was funded by Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado da Bahia (FAPESB).</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the dissertation of doctoral submitted by Cristiane Maria Carvalho Costa Dias, from Escola Bahiana de Medicina e Sa&#250;de P&#250;blica (EBMSP).</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Respuesta circulatoria a la caminata de 50m en la unidad coronaria, en la s&#237;ndrome coronaria aguda</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: Ausencia de t&#233;cnica estandarizada y de monitoreo para iniciarse la rehabilitaci&#243;n de pacientes con s&#237;ndrome coronaria aguda (SCA), en la unidad coronaria. OBJETIVO: Describir la t&#233;cnica y la respuesta circulatoria a la caminata de 50m (C50m)./ M&#201;TODOS: Estudio experimental, transversal, con 65 pacientes con SCA; el n&#250;mero de 36 (54%) de ellos con infarto agudo de miocardio (IAM), Killip I; un total de 29 (45,2%) con angina instable (AI); el 61,5% del sexo masculino, edad 62,8 &#177; 12,7 a&#241;os. Caminata con inicio 45 &#177; 23 horas post internaci&#243;n. Se calcularon la presi&#243;n arterial sist&#243;lica (PAS mmHg) y diast&#243;lica (PAD mmHg), la frecuencia cardiaca (FC bpm), el doble producto (PAS mmHg X FC bpm), la saturaci&#243;n perif&#233;rica de ox&#237;geno (SpO2%), el tiempo de caminata y la percepci&#243;n del esfuerzo a trav&#233;s de la escala de Borg (EB). Se obtuvieron mediciones en las posiciones supina, sentada y ortostasis (fase 1 - estr&#233;s gravitacional), al final de la caminata y del post reposo de 5 minutos (fase 2 - estr&#233;s f&#237;sico). RESULTADOS: Se observ&#243; un aumento de la frecuencia cardiaca (FC) al estr&#233;s gravitacional en la posici&#243;n sentada (&#916; = 4,18) y en ortostasis (&#916; = 2,69), (p &lt; 0,001). Hubo elevaci&#243;n post caminata de la PAS (&#916; = 4,84), (p &lt; 0,001); FC (&#916; = 4,68), (p &lt; 0,001); (DP) (&#916; = 344,97), (p = 0,004); y descenso de la SpO2 (&#916; = -1,42), (p &lt; 0,001), con retorno de los valores basales tras 5 minutos. El tiempo de caminata fue de 2'36" &#177; 1'17". Se observ&#243; una buena tolerancia al ejercicio mediante la EB. Respuesta de la PAS &gt; 142 mmHg al sentarse se asoci&#243; al aumento significativo (p = 0,031) de 11 mmHg al ejercicio en 13 pacientes con sobrepeso/obesidad y el 85% con hipertensi&#243;n. Se verificaron efectos adversos en 19 (29,2%) pacientes, v&#233;rtigos en el 23,1%, con interrupci&#243;n de la caminata en tres de ellos. CONCLUSI&#211;N: En esta muestra, tras 24 horas del evento coronario, no se verificaron efectos colaterales graves a la C50m.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Infarto de miocardio</kwd>
        <kwd>angina inestable</kwd>
        <kwd>rehabilitaci&#243;n</kwd>
        <kwd>actividad motora</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="tx-body3">
          <label>
            <bold>Respuesta circulatoria a la caminata de 50m en la unidad coronaria, en la s&#237;ndrome coronaria aguda</bold>
          </label>
          <p>
            <bold>Cristiane Maria Carvalho Costa Dias; Ana C&#233;lia Carneiro de Almeida Maiato; K&#225;tia Maria Moreno Baqueiro; Alessandra Maia Furtado Fiqueredo; Fernanda Warken Rosa; Janaina Oliveira Pitanga; Ludmila Ivo Cat&#227;o de Souza; Arm&#234;nio Costa Guimar&#227;es</bold>
          </p>
        </fn>
      </p>
      <p>Escola Bahiana de Medicina e Sa&#250;de P&#250;blica (EBMSP), Hospital Alian&#231;a (HA), Salvador, BA - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO:</bold> Ausencia de t&#233;cnica estandarizada y de monitoreo para iniciarse la rehabilitaci&#243;n de pacientes con s&#237;ndrome coronaria aguda (SCA), en la unidad coronaria.</p>
      <p><bold>OBJETIVO:</bold> Describir la t&#233;cnica y la respuesta circulatoria a la caminata de 50m (C50m)./</p>
      <p> M&#201;TODOS: Estudio experimental, transversal, con 65 pacientes con SCA; el n&#250;mero de 36 (54%) de ellos con infarto agudo de miocardio (IAM), Killip I; un total de 29 (45,2%) con angina instable (AI); el 61,5% del sexo masculino, edad 62,8 &#177; 12,7 a&#241;os. Caminata con inicio 45 &#177; 23 horas post internaci&#243;n. Se calcularon la presi&#243;n arterial sist&#243;lica (PAS mmHg) y diast&#243;lica (PAD mmHg), la frecuencia cardiaca (FC bpm), el doble producto (PAS mmHg X FC bpm), la saturaci&#243;n perif&#233;rica de ox&#237;geno (SpO<sub>2</sub>%), el tiempo de caminata y la percepci&#243;n del esfuerzo a trav&#233;s de la escala de Borg (EB). Se obtuvieron mediciones en las posiciones supina, sentada y ortostasis (fase 1 - estr&#233;s gravitacional), al final de la caminata y del post reposo de 5 minutos (fase 2 - estr&#233;s f&#237;sico).</p>
      <p><bold>RESULTADOS:</bold> Se observ&#243; un aumento de la frecuencia cardiaca (FC) al estr&#233;s gravitacional en la posici&#243;n sentada (&#916; = 4,18) y en ortostasis (&#916; = 2,69), (p &lt; 0,001). Hubo elevaci&#243;n post caminata de la PAS (&#916; = 4,84), (p &lt; 0,001); FC (&#916; = 4,68), (p &lt; 0,001); (DP) (&#916; = 344,97), (p = 0,004); y descenso de la SpO<sub>2</sub> (&#916; = -1,42), (p &lt; 0,001), con retorno de los valores basales tras 5 minutos. El tiempo de caminata fue de 2'36" &#177; 1'17". Se observ&#243; una buena tolerancia al ejercicio mediante la EB. Respuesta de la PAS &gt; 142 mmHg al sentarse se asoci&#243; al aumento significativo (p = 0,031) de 11 mmHg al ejercicio en 13 pacientes con sobrepeso/obesidad y el 85% con hipertensi&#243;n. Se verificaron efectos adversos en 19 (29,2%) pacientes, v&#233;rtigos en el 23,1%, con interrupci&#243;n de la caminata en tres de ellos.</p>
      <p><bold>CONCLUSI&#211;N:</bold> En esta muestra, tras 24 horas del evento coronario, no se verificaron efectos colaterales graves a la C50m.</p>
      <p><bold>Palabras clave:</bold> Infarto de miocardio, angina inestable, rehabilitaci&#243;n, actividad motora.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>La rehabilitaci&#243;n f&#237;sica precoz de pacientes con eventos cardiacos agudos empez&#243; con el <italic>armchair treatment</italic> propuesto por Mitchell et al<sup>1</sup>, en Boston, en 1953, para pacientes con infarto agudo de miocardio (IAM). Ese procedimiento ten&#237;a como objetivo reducir las complicaciones pulmonares, embolicas, auton&#243;micas y neuromusculares advenidas de reposo en cama, que se prolongaban por tres a seis semanas<sup>1</sup>. Convertino<sup>2</sup>, en 2003, describe que no es raro el reposo prolongado en cama post IAM y post angioplastia, principalmente en la unidad coronaria (UCO). Alerta sobre la frecuencia de intolerancia ortost&#225;tica y taquicardia refleja, efectos adversos comunes en esos pacientes al asumir la posici&#243;n en ortostasis. Se debe balancear el programa de movilizaci&#243;n del paciente entre el riesgo de la movilizaci&#243;n precoz y los efectos da&#241;osos secundarios al reposo en cama<sup>3</sup>. </p>
      <p>La pr&#225;ctica de la rehabilitaci&#243;n cardiovascular fase hospitalaria (RCV1) forma parte de la UCO, aplicable a la SCA<sup>2,4-9</sup>, y se la inicia, si posible, de 12 a 24 horas post evento<sup>3,7</sup>. La mayor&#237;a de los protocolos indica el estr&#233;s gravitacional (EG) y la caminata como componentes de la RCV1<sup>7-12</sup>. Sin embargo, no hay consenso en cuanto al monitoreo tanto de la respuesta circulatoria - que revela el grado de estr&#233;s impuesto al sistema cardiovascular<sup>13</sup>-, como de la distancia y del tiempo de la caminata. </p>
      <p>Otro aspecto preocupante es no advertirse a los profesionales del equipo interdisciplinario sobre la heterogeneidad de esa poblaci&#243;n, con varios factores de riesgo asociados<sup>3</sup>, potencial para inducir complicaciones al EG y en la caminata. Con base en la pr&#225;ctica emp&#237;rica de la RCV1 en una UCO, se busc&#243; describir la t&#233;cnica de la C50m, en sus fases de EG y estr&#233;s f&#237;sico, de acuerdo con la respuesta circulatoria, permiti&#233;ndose una programaci&#243;n m&#225;s racional y segura de la RCV1. </p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Se realiz&#243; un estudio experimental, transversal, en la UCO de hospital privado en la ciudad de Salvador-BA, entre abril de 2006 y enero de 2007. Se incluyeron a pacientes portadores de SCA con liberaci&#243;n m&#233;dica para deambular, que no hubieran sido sometidos a tratamiento quir&#250;rgico para revascularizaci&#243;n del miocardio, y orientados en el tiempo y en el espacio. Se excluyeron a pacientes con liberaci&#243;n m&#233;dica que se recusaron a firmar el formulario de consentimiento informado y alguna condici&#243;n que, al momento de la C50m, pudiera poner el paciente en riesgo, tales como queja de dolor precordial, disnea, arritmia parox&#237;stica, alteraci&#243;n aguda del segmento ST y de la onda T, FC basal &gt;100 bpm, SpO<sub>2</sub> &lt; 92%; 100 &lt;PAS &gt; 160 mmHg y PAD &gt;100 mmHg<sup>6 </sup>. </p>
      <p>Durante la recolecci&#243;n, se reclutaron a 94 pacientes con diagn&#243;stico de SCA y, de ese total, se excluyeron a 23 pacientes de acuerdo con los criterios de exclusi&#243;n. Un paciente desisti&#243; y cinco rechazaron el tratamiento. La muestra estaba compuesta por 65 pacientes, cuyas principales caracter&#237;sticas cl&#237;nicas y demogr&#225;ficas est&#225;n presentadas en la <xref ref-type="table" rid="tab01-body3">Tabla 1</xref>. De ese total, 36 pacientes (54,8%) ten&#237;an infarto agudo de miocardio: 24 (36,9%) sin supradesnivelaci&#243;n ST y 12 (18,5%) con supradesnivelaci&#243;n ST; y 29 (45,2%) ten&#237;an angina inestable (AI). Hubo predominancia del sexo masculino, con 40 pacientes (61,5%), y el edad promedio fue de 62,8 &#177;12,7 a&#241;os (variaci&#243;n de 38 a 94 a&#241;os). El total de 30 pacientes (46,2%) ten&#237;an educaci&#243;n superior, y cinco (7,7%) eran analfabetos o ten&#237;an la primaria incompleta. Del total, 38 individuos (58,5%) eran econ&#243;micamente activos.</p>
      <table-wrap id="tab01-body3">
        <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt01-es.jpg"/></table-wrap>
      <p>De todos los factores de riesgo asociados, siguen a continuaci&#243;n los m&#225;s frecuentes: sedentarismo (76,9%), sobrepeso/obesidad (69,2%), sexo masculino (61,5%) e hipertensi&#243;n arterial (63,1%). El &#237;ndice de masa corp&#243;rea (IMC) mostr&#243; un promedio elevado (27 &#177; 4,0 kg/m<sup>2</sup>) en el intervalo de sobrepeso/obesidad. El estudio cineangiogr&#225;fico, realizado en 47 pacientes (72,3%), evidenci&#243; obstrucci&#243;n <underline>&gt;</underline>70%, uniarterial en 11 (16,9%), biarterial en 12 (18,3%) y triarterial en ocho individuos (12,3%), y nueve (13,8%) se trataron con angioplastia. Se utiliz&#243; vasodilatador en 52 pacientes (80%) y betabloqueante en 47 (72,3%). </p>
      <p>La investigaci&#243;n fue aprobada por el Comit&#233; de &#201;tica en Investigaci&#243;n de la Escuela Bahiana de Medicina (CEP n&#186; 75/2005). </p>
      <p>
        <bold>Caminata de 50m </bold>
      </p>
      <p>La distancia de 50m represent&#243; el recorrido habitual de los pacientes en su primera caminata post evento, ya realizada en la rutina de la UCO, por el fisioterapeuta. Las variables elegidas para el monitoreo representan los principales indicadores de la actividad del coraz&#243;n como bomba y de la regulaci&#243;n de la hemodin&#225;mica de la circulaci&#243;n sangu&#237;nea: como reflejo indirecto del consumo de oxigeno mioc&#225;rdico tuvimos la FC, PAS, PAD, y el doble producto (DP) y SpO<sub>2</sub>, como reflejo de extracci&#243;n perif&#233;rica de ox&#237;geno. La escala de Borg (EB) complement&#243; la evaluaci&#243;n subjetiva de la respuesta al estr&#233;s inducido por la caminata. </p>
      <p>Se monitore&#243; la respuesta circulatoria a la C50m en dos fases: </p>
      <p>&#8226; Fase 1 - dec&#250;bito dorsal a 0&#186;, sentado en la cama con las piernas pendientes y en ortostasis.  </p>
      <p> &#8226; Fase 2 - tras 3 minutos en ortostasis<sup>14</sup>, durante y al final de la caminata, y en la fase de recuperaci&#243;n y tras 5 minutos<sup>15,16</sup>.  </p>
      <p>Todos los pacientes fueron sometidos a evaluaci&#243;n cl&#237;nica, con registro de datos antropom&#233;tricos y cl&#237;nicos. Se calcularon el peso y la altura en balanza antropom&#233;trica W-200 (Welmy - Brasil). El c&#225;lculo del &#237;ndice de masa corp&#243;rea se hizo mediante la f&#243;rmula de Quetelet: IMC = peso en kg/altura en m<sup>2</sup>. </p>
      <p>La medici&#243;n de la presi&#243;n arterial (PA) se hizo en conformidad con las IV Directrices Brasile&#241;as de Hipertensi&#243;n<sup>17</sup>, utiliz&#225;ndose la t&#233;cnica auscultatoria, con esfigmoman&#243;metro aneroide y tensi&#243;metro Missouri (Mikatos-Brasil). La FC fue determinada con un Polar (Electro OY- Filand) y la SpO<sub>2</sub> con ox&#237;metro de mu&#241;eca port&#225;til 1001 (Moriya - Brasil). Se calcul&#243; la duraci&#243;n de la caminata por medio de cron&#243;metro Ferrari (Oregon - EUA). El c&#225;lculo de las variables circulatorias obedeci&#243; a esta secuencia: la PA tras 5 minutos en dec&#250;bito dorsal a 0&#186;, en el primer minuto tras sentar, en el primer y tercer minutos tras asumir la ortostasis, en el primer minuto al final de la caminata y en el quinto minuto de recuperaci&#243;n; se monitorearon de modo continuo la FC y la SpO<sub>2</sub>, con registro de los valores coincidiendo con el inicio de la medici&#243;n de la PA. </p>
      <p>Al inicio de la caminata, el paciente fue interrogado respecto a la presencia de cualquier inc&#243;modo y si estaba dispuesto a realizarla. Si fuera el caso de presentar alg&#250;n tipo de inc&#243;modo se orient&#243; al paciente que se interrumpiera la caminata. Se utiliz&#243; la EB modificada (0-10), por ser la m&#225;s actualizada<sup>18</sup>. Aplicada al inicio y al final de la caminata, se orientaron a los pacientes que no ultrapasara el nivel cuatro (un poco fatigoso), l&#237;mite m&#225;ximo de seguridad para la actividad f&#237;sica en esta fase<sup>6</sup>. La C50m fue seguida por el fisioterapeuta que registr&#243; la FC<sub>m&#225;x</sub> y SpO<sub>2min</sub>; no hubo est&#237;mulo verbal con relaci&#243;n al ritmo y a la velocidad de la caminata. El paciente mismo estableci&#243; su ritmo; al final de la caminata, se registraron par&#225;metros circulatorios y el nivel de la EB.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>
        <bold>C&#225;lculo del tama&#241;o de la muestra</bold>
      </p>
      <p>Ese c&#225;lculo tom&#243; como base la variable de desenlace FC, que se considera como indicador de la respuesta funcional del paciente. La hip&#243;tesis a probarse fue de que la FC aumentar&#237;a en funci&#243;n del estr&#233;s f&#237;sico de la C50m, y se estimar&#237;a la magnitud de ese efecto (E) en +4bpm, caracteriz&#225;ndose el an&#225;lisis como unidireccional. A su vez, se estim&#243; la variabilidad del desenlace (aumento de la FC) con base en la desviaci&#243;n est&#225;ndar (S) del promedio de la FC, lo que se calcul&#243; como &#188; de una variaci&#243;n de la FC de 70 a 100 bpm (tomando en consideraci&#243;n que muchos de eses pacientes usaban BB): DP = 30&#247;4= &#177;7,5 bpm. Se calcul&#243;, por lo tanto, la magnitud de la amplitud estandarizada del efecto (E/S), y se la defini&#243; mediante el cuociente de la amplitud total del intervalo (4) a trav&#233;s de la DP (7,5): 4&#247;7,5 = 0,53. Con esos valores y para un a = 0,05 (nivel de significancia) y &#946; = 0,20 (poder del estudio), se encontr&#243; un N de 51 pacientes, lo que, al sumarse m&#225;s el 20% para compensar p&#233;rdidas, alcanz&#243; un m&#237;nimo de 62 pacientes<sup>19</sup>.</p>
      <p>Las variables independientes siguen a continuaci&#243;n: sexo, edad, actividad f&#237;sica, IMC, tipo de SCA, dislipidemia, hipertensi&#243;n, diabete, tabaquismo, uso de vasodilatador y betabloqueante. Las variables dependientes siguen a continuaci&#243;n: duraci&#243;n de la caminata, PAS, PAD, FC, DP, SpO<sub>2 </sub> y EB. El banco de datos y el an&#225;lisis descriptivo y anal&#237;tico se los realizaron con el auxilio del <italic>software</italic> Statistical Package for Social Sciences (SPSS), versi&#243;n 12.0 para Windows. Se realiz&#243; el an&#225;lisis de normalidad de la distribuci&#243;n de variables continuas por medio de la prueba de Kolmogorov-Smirnov.</p>
      <p>Se expresaron las variables categ&#243;ricas en porcentajes (%), las variables continuas, con distribuci&#243;n normal, en promedio y desviaci&#243;n est&#225;ndar (X&#177;DE) y con distribuci&#243;n asim&#233;trica en mediana e intervalo intercuart&#237;lico. </p>
      <p>Se utiliz&#243; la prueba Chi-cuadrado para comparaci&#243;n de las variables categ&#243;ricas y, cuando de su inadecuaci&#243;n, se emple&#243; la prueba exacta de Fischer. Se efectu&#243; el an&#225;lisis de comparaci&#243;n de la EB (pre y post) mediante la prueba de McNemar.</p>
      <p>La significancia estad&#237;stica de la diferencia entre los promedios de las variables en las fases del EG y de la caminata se la estableci&#243; por medio de la prueba t de Student para muestras pareadas y la comparaci&#243;n de las mismas variables entre los predictores de riesgo mediante la prueba t de Student para muestras independientes. En algunos casos, se hicieron dichas comparaciones por medio de las pruebas U y T de Wilcoxon, respectivamente. El nivel de significancia fue del 5%.</p>
      <p>El estudio fue financiado por la Fundaci&#243;n de Amparo a la Investigaci&#243;n del Estado de Bahia.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>
        <bold>Caminata de 50m</bold>
      </p>
      <p>La C50m se aplic&#243; 45,0 &#177; 23,0 horas post internaci&#243;n, variando de 24 a 48 horas en 27 (41,5%) pacientes, 10 (27,8%) de los que ten&#237;an IAM; de 48 a 72 horas en 33 (50,8%) y entre 96 y 120 horas en cuatro (6,2%); solamente un paciente realiz&#243; la prueba al quinto d&#237;a de ingreso. La variabilidad del tiempo de aplicaci&#243;n result&#243; del tiempo de la &#250;ltima crisis de angina y de la realizaci&#243;n de cateterismo y/o angioplastia, con un periodo de espera de &#177; 24 horas. </p>
      <p>
        <bold>Comportamiento de variables circulatorias y duraci&#243;n de la C50m</bold>
      </p>
      <p>Los valores basales del promedio de las variables circulatorias en estudio, calculadas en dec&#250;bito dorsal a 0&#186;, fueron las que siguen: PAS 128,8 &#177;15,0 mmHg; PAD 73,8 &#177;12,5 mmHg; FC 70,9&#177;10,4 bpm; DP 10.007 &#177; 77,07 mmHgXbpm; y SpO<sub>2 </sub>95&#177;2,0 %, valores normales. El cambio de posici&#243;n del dec&#250;bito dorsal de 0&#186; para la posici&#243;n sentada y posterior ortostasis provoc&#243; un aumento significativo de la FC, &#916;+4,18 bpm (p&lt;0,001) y &#916; +2,69 bpm (p &lt; 0,001), respectivamente, con todo sin repercusi&#243;n cl&#237;nica (<xref ref-type="table" rid="tab02-body3">Tab. 2</xref>).</p>
      <table-wrap id="tab02-body3">
        <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt02-es.jpg"/></table-wrap>
      <p>Al final de la caminata, se observ&#243; un aumento en los valores de la PAS, &#916; +4,84 mmHg (p &lt; 0,001), FC, &#916; +4,68 bpm (p &lt; 0,001), y DP, &#916; +344,97 mmHgxbpm (p = 0,004), y baja de la SpO<sub>2</sub>&#916; -1,42% (p &lt; 0,001), todos significativos, pero sin repercusi&#243;n cl&#237;nica. En la fase de recuperaci&#243;n, tras cinco minutos en la posici&#243;n sentada, las variables estudiadas presentaron reducci&#243;n significativa (PAS, &#916; -4,53 mmHg, p&lt;0,024, FC, &#916; -9,06 bpm, DP, &#916; - 869,42 mmHgxbpm, p&lt;0,001 y PAD, &#916; -3,14 mmHg, p=0,006), a excepci&#243;n de la SpO<sub>2 </sub>que evidenci&#243; aumento significativo, &#916;+2,16%, p&lt;0,001, todas ellas volviendo r&#225;pidamente a los valores basales (<xref ref-type="table" rid="tab02-body3">Tab. 2</xref>) La duraci&#243;n de la C50m present&#243; valor promedio de 2,5 &#177; 1,3 min. </p>
      <p>La percepci&#243;n de las fases del EG y estr&#233;s f&#237;sico por la EB revel&#243; un desv&#237;o hacia la derecha con relaci&#243;n a los scores basales. En la fase pre caminata, 33 (53,2%) individuos declararon "ausencia de disnea" (escore 0), 27 (43,5%) "muy muy leve" y de "muy leve a leve" (score de 0,5 a 2) y 2 (3,2%) "moderada" (score 3). Al final de la caminata, la distribuci&#243;n de esas percepciones pas&#243; a 25 (40,3%), 29 (46,8%) y 7 (11,3%), respectivamente, con un paciente m&#225;s (1,6%) cuya disnea se volvi&#243; m&#225;s intensa (score 4). Esa paciente ten&#237;a AI, 64 a&#241;os, era fumadora y obesa.</p>
      <p>
        <bold>Variabilidad de las variables circulatorias entre los predictores de riesgo</bold>
      </p>
      <p>El EG de la posici&#243;n sentada desde el dec&#250;bito dorsal 0&#186; provoc&#243; variaci&#243;n divergente del &#916; PAS, con significancia estad&#237;stica, pero sin repercusi&#243;n cl&#237;nica, en sedentarios y diab&#233;ticos. En los sedentarios, hubo aumento del &#916;PAS de +1,68 mmHg, mientras que en los f&#237;sicamente activos se verific&#243; una reducci&#243;n de -4,71 mmHg (p = 0,030) (<xref ref-type="table" rid="tab03-body3">Tab. 3</xref>). En los diab&#233;ticos, hubo reducci&#243;n de la &#916;PAS de -3,5 mmHg, mientras que en los no diab&#233;ticos se verific&#243; un aumento de +2 mmHg (p = 0,012) (<xref ref-type="table" rid="tab03-body3">Tab. 3</xref>). La variaci&#243;n de la FC fue positiva en todos, incluso en los pacientes en uso de betabloqueante.</p>
      <table-wrap id="tab03-body3">
        <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt03-es.jpg"/></table-wrap>
      <p>En relaci&#243;n con el EG de la ortostasis, no hubo variaci&#243;n significativa de la PAS, pero se verific&#243; variaci&#243;n significativa del comportamiento de la FC entre pacientes con edad menor y <underline>&gt;</underline> 63 a&#241;os de edad (valor de la mediana de edad de la muestra), pero sin repercusi&#243;n cl&#237;nica. Los individuos con edad <underline>&gt;</underline> 63 a&#241;os presentaron un &#916;FC de +0,73 bpm, en oposici&#243;n al aumento de +4,72 bpm en los pacientes con edad &lt; 63 a&#241;os, p = 0,002 (<xref ref-type="table" rid="tab03-body3">Tab. 3</xref>). </p>
      <p>Tras el estr&#233;s f&#237;sico, el &#916; PAS en los diab&#233;ticos fue de 2,17 mmHg, mientras que en los no diab&#233;ticos fue de 6,41 mmHg, con valor de p muy pr&#243;ximo del nivel de significancia (0,061). En los diab&#233;ticos, el &#916;FC fue de +8,39 bpm, significativamente mayor que en los no diab&#233;ticos (&#916;FC +2,49 bpm, p = 0,017) (<xref ref-type="table" rid="tab03-body3">Tab. 3</xref>). Con el uso de betabloqueante, hubo cambio en la FC y en la PAS, pero sin significancia estad&#237;stica y cl&#237;nica. Respecto a la duraci&#243;n, la C50m no evidenci&#243; diferencia significativa entre los predictores de riesgo. Sin embargo, en los individuos con edad <underline>&gt;</underline> 63 a&#241;os, el promedio de duraci&#243;n de la C50m fue el m&#225;s largo, 2 min 52s &#177; 1,37, en oposici&#243;n a los f&#237;sicamente activos, con el menor promedio, 1 min 98s &#177;0,80.</p>
      <p>
        <bold>Comportamiento de valores extremos en respuesta a la C50m</bold>
      </p>
      <p>El grupo que present&#243; valores de la PAS <underline>&gt;</underline> 142 mmHg al sentarse revel&#243; aumento significativo de la &#916;PAS de +2,00 mmHg (p = 0,013) con relaci&#243;n al dec&#250;bito dorsal de 0&#186;, con valor m&#225;ximo de la PAS de 154 mmHg; tras la C50m, el &#916;PAS aument&#243; de +11 mmHg, p = 0,013, con valor m&#225;ximo de la PAS de 160 mmHg. En la recuperaci&#243;n, el &#916; PAS fue de -3 mmHg, sin significancia y el valor m&#225;ximo de la PAS baj&#243; para 153 mmHg (<xref ref-type="table" rid="tab04-body3">Tab. 4</xref>). La FC revel&#243; aumento significativo al sentarse, con &#916;FC de +4,00 bpm, p = 0,004, alta m&#225;xima de 80 bpm; y tras la caminata, &#916;FC de +3,5 bpm, p &lt; 0,001, alta m&#225;xima de 81 bpm, con reducci&#243;n significativa en la fase de recuperaci&#243;n (&#916;FC-6,50 bpm, p = 0,017), alta m&#225;xima de 75 bpm (<xref ref-type="table" rid="tab04-body3">Tab. 4</xref>). En los pacientes que presentaron PAS <underline>&lt;</underline> 114 mmHg, al sentarse, &#233;sta se mantuvo estable, mientras que la FC present&#243; aumento significativo (&#916;FC +4,5 bpm, p = 0,004) al sentarse, en la ortostasis (&#916;FC +3,0 bpm, p = 0,013); y tras la caminata (&#916;FC +5,0 bpm, p = 0,014), con aumento cumulativo de 12,5 bpm y alta m&#225;xima en la caminata de 95 bpm. En la recuperaci&#243;n, hubo desaceleraci&#243;n significativa de 10 bpm (p = 0,001), bajando el alta m&#225;xima de la FC para 88 bpm (<xref ref-type="table" rid="tab04-body3">Tab. 4</xref>).</p>
      <table-wrap id="tab04-body3">
        <graphic xlink:href="1678-4170-abc-92-02-0135-00010-gt04-es.jpg"/></table-wrap>
      <p>De los predictores de riesgo considerados, todos los 13 pacientes (100,0%) que presentaron respuesta extrema con PAS <underline>&gt;</underline> 142 mmHg ten&#237;an sobrepeso/obesidad, comparados a los 8 (50,0%) de los 16 individuos con respuesta extrema de la PAS <underline>&lt;</underline> 114 mmHg, p = 0,030; y 11 pacientes (85,0%) ten&#237;an hipertensi&#243;n <italic>vs</italic> 7 (44,0%) respectivamente, p = 0,0524. </p>
      <p>
        <bold>Efectos adversos a la caminata de 50m</bold>
      </p>
      <p>Se observaron efectos adversos en la fase de EG de la ortostasis en 19 pacientes (29,2%). El v&#233;rtigo fue el frecuente y ocurri&#243; en 15 individuos (23,1%), seguido de hipotensi&#243;n postural en cuatro pacientes (6,3%). A excepci&#243;n de tres pacientes, en los cuales hubo necesidad de interrupci&#243;n de la caminata, un paciente present&#243; precordialgia, otro, pico hipertensivo (PA = 168 X 110 mmHg), y el tercer, hipotensi&#243;n con v&#233;rtigo (PA = 100 X 88 mmHg, con &#916; PAS =-18 mmHg). Todos los tres presentaron sudoraci&#243;n profusa y estaban en uso de betabloqueante y vasodilatador. </p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>El presente estudio describe el comportamiento de variables circulatorias a la C50m en la UTIC, en pacientes con SCA, en conformidad a la directriz de la SBC, que preconiza la rehabilitaci&#243;n cardiovascular en la fase hospitalaria para pacientes con ese perfil cl&#237;nico<sup>6,8,9,11</sup>. Para el &#233;xito de esa rehabilitaci&#243;n, sin embargo, es necesario monitorear la respuesta circulatoria, pr&#225;ctica realizada en nuestro estudio.</p>
      <p>Los factores de riesgo asociados son habituales entre pacientes con ese tipo de patolog&#237;a, como revela el elevado porcentaje de pacientes sedentarios, con sobrepeso/obesidad, hipertensos, diab&#233;ticos, lo que constituye riesgo adicional para la aplicaci&#243;n de la C50m. Este hecho indica la importancia de estandarizarse y monitorearse el impacto sobre el aparato cardiovascular del EG y del estr&#233;s f&#237;sico de la C50m, como medio de garantizarse el proceso de rehabilitaci&#243;n precoz. Tomando en consideraci&#243;n las alteraciones fisiopatol&#243;gicas resultantes del reposo en cama, la literatura evidencia la importancia de incrementarse el EG y la caminata as&#237; que posible<sup>2</sup>. Esa pr&#225;ctica, con todo, s&#243;lo se indica a pacientes con SCA estable<sup>6, 8,9,11</sup>.</p>
      <p>El promedio del tiempo de aplicaci&#243;n de la C50m refleja el cuidado de que se debe iniciar la rehabilitaci&#243;n activa en condiciones estables, con espera de 24 horas post precordialgia y/o post cateterismo. Los hallazgos en la literatura difieren respecto al periodo en que se debe iniciar la caminata post evento coronario agudo, de la distancia inicial a recorrerse y sobre la conveniencia del monitoreo de variables circulatorias en las fases del EG y de la caminata<sup>6-9,11</sup>. En el particular, encontramos el estudio de Debusk et al.<sup>20</sup> que monitorearon la PA en la posici&#243;n sentada y en ortostasis, antes de iniciarse la caminata. Recientemente, Nogueira et al.<sup>21</sup> aplicaron, con &#233;xito, la prueba de caminata de 6 minutos, en la primera semana post IAM, con el objetivo de evaluarse la capacidad funcional. </p>
      <p>Hay pocos datos en la literatura sobre la respuesta circulatoria al EG de pacientes con SCA que han estado en reposo en dec&#250;bito dorsal. En este estudio, la respuesta de la PAS y PAD al EG sentado y en ortostasis provoc&#243; una peque&#241;a variabilidad, sugiriendo que la mayor&#237;a de esos pacientes, sometidos al reposo por tiempo igual o superior a 24 horas y al uso de medicaci&#243;n vasodilatadora y betabloqueante, conserv&#243; sus reflejos posturales activos, y mantuvo la integridad del ajuste circulatorio perif&#233;rico a los cambios de posici&#243;n del cuerpo<sup>16</sup>. Ese hecho sugiere una respuesta positiva al tratamiento fisioterap&#233;utico pre rehabilitaci&#243;n, reduciendo el riesgo de hipotensi&#243;n postural post reposo en cama<sup>2</sup>. </p>
      <p>La respuesta de la FC al EG sentado y en ortostasis se mostr&#243; adecuada, adem&#225;s de evidenciar la actuaci&#243;n fisiol&#243;gica de ese sensible mecanismo de ajuste a los cambios posturales, por medio del aumento de la actividad simp&#225;tica<sup>22,23</sup>. El resultado de ese ajuste fisiol&#243;gico entre los cambios de la PA y de la FC se traduce en la leve baja del DP, lo que mantiene estable el consumo de ox&#237;geno miocardio, y tambi&#233;n se revela por la estabilidad de la SpO<sub>2</sub><sup>22</sup>. Dichos datos evidencian que la fase de EG en la C50m no ocasiona inestabilidad hemodin&#225;mica, desde que a los pacientes se seleccionen apropiadamente y se les monitorean. Sin embargo, alrededor de &#188; de los pacientes (23,1%) se quejaron de v&#233;rtigo en respuesta al EG. Aunque de leve intensidad, ese dato sugiere la conveniencia de maniobras fisioterap&#233;uticas en el dec&#250;bito dorsal, en la fase pre estr&#233;s gravitacional, con el objetivo de intentarse reducir ese tipo de queja, indicadora de que el ajuste gravitacional no fue totalmente satisfactorio.</p>
      <p>La fase de estr&#233;s f&#237;sico representada por la C50m mostr&#243; una respuesta cardiovascular positiva, representada por la variabilidad fisiol&#243;gica de las variables circulatorias<sub>, </sub>accionada por reflejo auton&#243;mico simp&#225;tico, llevando al aumento del d&#233;bito cardiaco, a fin de satisfacerse la elevaci&#243;n de la demanda muscular en ox&#237;geno ante el ejercicio<sup>13,24</sup>. El grado de variaci&#243;n de esos par&#225;metros circulatorios evidenci&#243; que la C50m deflagr&#243; un estr&#233;s f&#237;sico apropiado a la capacidad funcional de esos pacientes, sin repercusi&#243;n cl&#237;nica. As&#237;, la duraci&#243;n promedio de la C50m se mostr&#243; suficiente para evaluarse el impacto del ejercicio sobre el sistema cardiovascular<sup>13,24</sup>, al mantenerse el esfuerzo en un l&#237;mite de bajo riesgo para esa poblaci&#243;n, en la fase aguda de un evento coronario. Al corroborarse esta asertiva, un protocolo reciente describe que la primera caminata post evento coronario debe ser de corta duraci&#243;n, con el tiempo promedio entre 1 y 2 minutos<sup>3</sup>. Se observ&#243; la respuesta fisiol&#243;gica a la carga de ejercicio en el quinto minuto de la fase de recuperaci&#243;n, cuando las variables circulatorias volvieron a valores pr&#243;ximos a los basales. </p>
      <p>La sensaci&#243;n de inc&#243;modo respiratorio durante la C50m, evaluada por medio de la EB modificada<sup>18</sup>, present&#243; pocas modificaciones con relaci&#243;n a la fase pre caminata. Vale resaltarse, sin embargo, que esas sensaciones no se hicieron seguir de anormalidades hemodin&#225;micas ni de la visualizaci&#243;n de inc&#243;modo respiratorio, inspeccionado por el investigador. Solamente un paciente (1,6%) declar&#243; estar "un poco fatigante", indicando que la C50m no fue un esfuerzo f&#237;sico que excedi&#243; la capacidad cardioventilat&#243;ria. Ante de lo expuesto, lo m&#225;s probable es que las quejas representaran la aprehensi&#243;n del paciente ante la movilizaci&#243;n precoz, a pesar del trabajo previo de sensibilizaci&#243;n relativo a los beneficios de la caminata.</p>
      <p>De todos los predictores de riesgo considerados, los sedentarios, los diab&#233;ticos y los individuos con 63 a&#241;os o m&#225;s de edad mostraron comportamiento de la PAS y la FC significativamente distinto de los activos, no diab&#233;ticos y con edad &lt; 63 a&#241;os en respuesta al EG y/&#243; al estr&#233;s f&#237;sico. Ese registro servir&#225; de gu&#237;a en cuanto a la posible diversidad de comportamiento entre esos grupos, y permite una observaci&#243;n m&#225;s atenta y posibles medidas preventivas cuando de la aplicaci&#243;n de la C50m en la rutina de la RCV1, en la UCO. De esta manera, los pacientes sedentarios presentaron aumento de la PAS al estr&#233;s gravitacional sentado, respuesta &#233;sta que puede resultar del bajo condicionamiento fisico<sup>25</sup>. Los diab&#233;ticos presentaron descenso de la PAS al asumirse la posici&#243;n sentada y el mayor aumento de la FC durante la caminata, lo que se puede relacionar a la neuropat&#237;a perif&#233;rica y a la desregulaci&#243;n auton&#243;mica com&#250;n en esos pacientes<sup>26</sup>. Los pacientes con edad <underline>&gt;</underline> 63 a&#241;os presentaron respuesta cronotr&#243;pica significativamente menor que los con edad &lt; 63 a&#241;os, lo que se puede atribuir, en parte, a la reducci&#243;n fisiol&#243;gica de la respuesta cronotr&#243;pica del nodo sinusal con la edad<sup>27</sup> y al uso de betabloqueante, lo que ocurri&#243; con el 63% de ellos.</p>
      <p>A pesar de no haber diferencia significativa en la duraci&#243;n de la caminata entre los grupos, se verific&#243;, adem&#225;s, que el promedio de tiempo m&#225;s elevado perteneci&#243; a los pacientes con edad <underline>&gt;</underline> 63 a&#241;os y con elevada frecuencia de sedentarismo, mientras que el menor tiempo fue el de los pacientes f&#237;sicamente activos, con la mayor&#237;a de &#233;stos con edad &lt;63 a&#241;os. Vale tomar en cuenta, asimismo, la reducci&#243;n en la capacidad al ejercicio con el envejecimiento<sup>27</sup>.</p>
      <p>El comportamiento de los pacientes con respuesta extrema al EG sentado revel&#243; respuesta distinta al estr&#233;s f&#237;sico. En el grupo de pacientes con PAS <underline>&gt;</underline> 142 mmHg, el aumento promedio de la PAS alcanz&#243; un alta m&#225;xima de 160 mmHg, l&#237;mite de seguridad en el protocolo del estudio<sup>6,8,9</sup>. La FC aument&#243; asimismo, con elevaci&#243;n de 7,5 bpm. Ese tipo de respuesta sugiere un aumento de la actividad simp&#225;tica adem&#225;s del requerido para el ajuste circulatorio consecuente al EG y al estr&#233;s f&#237;sico. Ello puede tener relaci&#243;n con el hecho de que todos los 13 pacientes ten&#237;an sobrepeso, con hipertensi&#243;n asociada en 11 individuos, condiciones que se desarrollan con aumento de la actividad simp&#225;tica<sup>13</sup>. En los pacientes con PAS&lt; 114 mmHg, todo el ajuste circulatorio ante el EG sentado y el estr&#233;s f&#237;sico se realiz&#243; mediante elevaci&#243;n de la FC, con alta m&#225;xima de la FC de 95 bpm, pr&#243;ximo al l&#237;mite de seguridad de 100 bpm<sup>6,8,9</sup>; la variabilidad de la PAS se mostr&#243; peque&#241;a, pero con tendencia al descenso. En el an&#225;lisis de la diversidad de respuesta circulatoria entre esos dos grupos, vale tomar en cuenta que, de los 16 pacientes con este &#250;ltimo comportamiento, el 50% ten&#237;an IMC normal y el 66,3% eran normotensos. Vale tambi&#233;n el registro de la atenci&#243;n y de la vigilancia del riesgo relativo al alta m&#225;xima de la PAS en el primer grupo y de la FC en el segundo grupo, en el proceso de la RCV1.</p>
      <p>Pese a los efectos adversos alrededor de 1/3 de los pacientes, pocos eventos tuvieron alguna repercusi&#243;n cl&#237;nica, y requirieron la suspensi&#243;n del proceso de rehabilitaci&#243;n -lo que ocurri&#243; en tres (4,8%) de ellos-; en los dem&#225;s los efectos fueron de leve intensidad, permiti&#233;ndose la ejecuci&#243;n de la caminata dentro de los criterios preestablecidos. V&#233;rtigo, que represent&#243; la queja m&#225;s frecuente, fue de poca intensidad y ocurri&#243; al asumirse la ortostasis, resultante, ciertamente, de la falta de estimulaci&#243;n de los reflejos posturales consecuente al reposo en cama<sup>2</sup> y al uso vasodilatador y betabloqueante. </p>
      <p>La interrupci&#243;n de la rehabilitaci&#243;n en tres pacientes obedeci&#243; a los criterios seguridad del protocolo, permiti&#233;ndose la pronta recuperaci&#243;n de los pacientes.</p>
      <p>
        <bold>Conclusiones</bold>
      </p>
      <p>Se puede considerar la C50m como un m&#233;todo bien tolerado de rehabilitaci&#243;n f&#237;sica para pacientes con SCA, en la UTI, a partir de 24 horas post evento, condicionada a la observancia de los l&#237;mites de seguridad de su protocolo. Son condiciones b&#225;sicas para su ejecuci&#243;n: paciente estable, en Killip clase I, liberado por el cardi&#243;logo y bien instruido por el fisioterapeuta; adem&#225;s de ello, es fundamental el control de PAS, FC y SpO<sub>2</sub> en sus fases.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio fue financiado por la Funda&#231;&#227;o de Amparo &#224; Pesquisa do Estado da Bahia (FAPESB).</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo es parte de disertaci&#243;n de Maestr&#237;a de Cristiane Maria Carvalho Costa Dias por la Escola Bahiana de Medicina e Sa&#250;de P&#250;blica (EBMSP).</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
